IMAX (IMAX) 10-Q 24 Jul 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014
Document and Entity Information [Abstract]	'
Entity Registrant Name	'IMAX Corporation
Entity Central Index Key	'0000921582
Document Type	'10-Q
Document Period End Date	30-Jun-14
Amendment Flag	'false
Document Fiscal Year Focus	'2014
Document Fiscal Period Focus	'Q2
Current Fiscal Year End Date	'--12-31
Entity Well Known Seasoned Issuer	'Yes
Entity Voluntary Filers	'Yes
Entity Current Reporting Status	'Yes
Entity Filer Category	'Large Accelerated Filer
Entity Common Stock Shares Outstanding	68,423,128

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Cash and cash equivalents	$75,087	$29,546
Accounts receivable, net of allowance for doubtful accounts of $837 (December 31, 2013 - $887)	73,023	73,074
Financing receivables	104,869	107,110
Inventories	16,764	9,825
Prepaid expenses	4,444	3,602
Film assets	6,994	7,076
Property, plant and equipment	150,819	132,847
Other assets	19,068	27,034
Deferred income taxes	21,158	24,259
Other intangible assets	26,979	27,745
Goodwill	39,027	39,027
Total assets	538,232	481,145
Liabilities	'	'
Accounts payable	12,488	19,396
Accrued and other liabilities	56,192	65,232
Deferred revenue	88,134	76,932
Total liabilities	156,814	161,560
Commitments and contingencies	'	'
Non-controlling interests	'	'
Non-controlling interests	37,546	0
Shareholders' equity	'	'
Capital stock common shares - no par value. Authorized - unlimited number. Issued and outstanding - 68,423,128 (December 31, 2013 - 67,841,233)	332,611	327,313
Other equity	41,056	36,452
Accumulated deficit	-29,307	-43,051
Accumulated other comprehensive loss	-488	-1,129
Total shareholders' equity	343,872	319,585
Total liabilities and shareholders' equity	$538,232	$481,145

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheet (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Assets	'	'
Allowance for doubtful accounts	$837	$887
Shareholders' equity	'	'
Common stock, share issued	68,423,128	67,841,233
Common stock, share outstanding	68,423,128	67,841,233

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues	'	'	'	'
Equipment and product sales	$19,502	$20,347	$25,856	$31,026
Services	39,742	41,519	68,614	68,175
Rentals	17,841	17,823	28,632	27,795
Finance income	2,060	2,024	4,240	4,008
Other	0	0	0	375
Revenues	79,145	81,713	127,342	131,379
Costs and expenses applicable to revenues	'	'	'	'
Equipment and product sales	9,366	11,416	13,085	16,475
Services	17,180	22,487	31,530	37,451
Rentals	4,805	4,175	8,525	7,628
Cost and expenses applicable to revenues, total	31,351	38,078	53,140	61,554
Gross margin	47,794	43,635	74,202	69,825
Selling, general and administrative expenses (including share-based compensation expense of $4.7 million and $7.9 million for the three and six months ended June 30, 2014, respectively (2013 - expense of $3.1 million and $5.9 million, respectively))	23,498	22,110	44,810	41,771
Gain on curtailment of postretirement benefit plan	0	0	0	-2,185
Research and development	3,309	3,659	6,908	7,293
Amortization of intangibles	416	373	818	737
Receivable provisions, net of recoveries	329	55	616	55
Impairment of available-for-sale investment	650	0	650	0
Income from operations	19,592	17,438	20,400	22,154
Interest income	24	12	40	25
Interest expense	-268	-348	-534	-693
Income from operations before income taxes	19,348	17,102	19,906	21,486
Provision for income taxes	-5,407	-4,813	-5,479	-6,016
Loss from equity-accounted investments, net of tax	-162	-434	-424	-654
Income from continuing operations	13,779	11,855	14,003	14,816
Net (loss) income from discontinued operations, net of tax	0	-39	355	-139
Net income	13,779	11,816	14,358	14,677
Less: Net income attributable to non-controlling interests	-472	0	-472	0
Net income attributable to Common Shareholders	$13,307	$11,816	$13,886	$14,677
Net income per share - basic and diluted:	'	'	'	'
Net income per share from continuing operations - basic	$0.19	$0.18	$0.20	$0.22
Net income per share from discontinued operations - basic	$0	$0	$0.01	$0
Net income per share - basic	$0.19	$0.18	$0.21	$0.22
Net income per share from continuing operations - diluted	$0.19	$0.17	$0.19	$0.21
Net income per share from discontinued operations - diluted	$0	$0	$0.01	$0
Net income per share - diluted	$0.19	$0.17	$0.20	$0.21

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Condensed Consolidated Statements of Operations [Abstract]	'	'	'	'
Compensation costs	$4.70	$3.10	$7.90	$5.90

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Net income	$13,779	$11,816	$14,358	$14,677
Unrealized net gain (loss) from cash flow hedging instruments	937	-498	127	-800
Realization of cash flow hedging net loss (gain) upon settlement	256	82	504	-48
Other-than-temporary impairment of available-for-sale investment	350	0	350	0
Foreign currency translation adjustments	-32	235	-178	-113
Gain on curtailment of postretirement benefit plan	0	0	0	398
Amortization of defined benefit plan actuarial loss	0	111	0	222
Other comprehensive income (loss), before tax	1,511	-70	803	-341
Income tax (expense) benefit related to other comprehensive income (loss)	-346	17	-165	85
Other comprehensive income (loss), net of tax	1,165	-53	638	-256
Comprehensive income	14,944	11,763	14,996	14,421
Less: Comprehensive loss attributable to non-controlling interests	-469	0	-469	0
Comprehensive income attributable to Common Shareholders	$14,475	$11,763	$14,527	$14,421

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Operating Activities	'	'
Net income	$14,358	$14,677
Net (income) loss from discontinued operations	-355	139
Adjustments to reconcile net income to cash from operations:	'	'
Depreciation and amortization	15,945	20,201
Write-downs, net of recoveries	1,579	55
Change in deferred income taxes	2,789	4,481
Stock and other non-cash compensation	8,090	6,317
Gain on curtailment of postretirement benefit plan	0	-2,185
Unrealized foreign currency exchange loss	64	874
Loss from equity-accounted investments	574	654
Investment in film assets	-5,147	-12,033
Changes in other non-cash operating assets and liabilities	-3,219	-25,001
Net cash provided by (used in) operating activities from discontinued operations	572	-139
Net cash provided by operating activities	35,250	8,040
Investing Activities	'	'
Purchase of property, plant and equipment	-16,581	-5,054
Investment in joint revenue sharing equipment	-10,801	-10,393
Investment in new business ventures	0	-1,000
Acquisition of other intangible assets	-970	-1,142
Net cash used in investing activities	-28,352	-17,589
Financing Activities	'	'
Issuance of subsidiary shares to non-controlling interests	40,491	0
Share issuance costs from the issuance of subsidiary shares to non-controlling interests	-3,556	0
Common shares issued - stock options exercised	2,657	3,992
Settlement of restricted share units	-790	0
Increase in bank indebtedness	0	12,000
Repayment of bank indebtedness	0	-5,000
Credit facility amendment fees paid	0	-2,088
Net cash provided by financing activities	38,802	8,904
Effects of exchange rate changes on cash	-159	83
Increase (decrease) in cash and cash equivalents during the period	45,541	-562
Cash and cash equivalents, beginning of period	29,546	21,336
Cash and cash equivalents, end of period	$75,087	$20,774

Basis_of_Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2014
Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]	'
Basis of Presentation	'
	1. Basis of Presentation
	IMAX Corporation, together with its wholly-owned subsidiaries (the “Company”), prepares its financial statements in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”).
	The condensed consolidated financial statements include the accounts of the Company together with its wholly-owned subsidiaries, except for subsidiaries which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. The nature of the Company's business is such that the results of operations for the interim periods presented are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all normal and recurring adjustments necessary to make the results of operations for the interim periods a fair statement of such operations.
	The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”). The Company has 11 film production companies that are VIEs. For 4 of the Company's film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE's economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. The Company continues to consolidate these entities, with no material impact on the operating results or financial condition of the Company, as these production companies have total assets of $0.2 million and total liabilities of $0.1 million as at June 30, 2014 (December 31, 2013 — assets and liabilities of $nil, respectively). For the other 7 film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at June 30, 2014, these 7 VIEs have total assets of $0.5 million (December 31, 2013 — $5.2 million) and total liabilities of $0.5 million (December 31, 2013 — $5.2 million). Earnings of the investees included in the Company's condensed consolidated statement of operations amounted to $nil and $nil for the three and six months ended June 30, 2014, respectively (2013 — $nil and $nil, respectively). The carrying value of these investments in VIEs that are not consolidated is $nil at June 30, 2014 (December 31, 2013 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the condensed consolidated statement of operations. The Company's exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $0.6 million at June 30, 2014 (December 31, 2013 — $1.5 million).
	The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) or ASC 320 − “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate. At June 30, 2014, the equity method of accounting is being utilized for investments with a total carrying value of $1.2 million (December 31, 2013 − $0.4 million). In 2013, the Company contributed $1.4 million, net of its share of costs, to a new business venture in the early-stage of start-up. In the first quarter of 2014, this new business venture was operational. The Company has determined it is not the primary beneficiary of these VIEs, and therefore these entities have not been consolidated. In addition, the Company has an investment in preferred stock of another business venture with a total cost of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at a total fair value of $0.7 million at June 30, 2014 (December 31, 2013 – $1.0 million). This investment is classified as an available-for-sale investment. The Company has invested $2.5 million in the preferred shares of an enterprise which meet the criteria for classification as an equity security under ASC 325 − “Investments − Others” (“ASC 325”) and accrued $0.5 million pertaining to warrants related to the respective investment (December 31, 2013 – investment of $2.5 million and $0.5 million pertaining to warrants). The total carrying value of investments in new business ventures at June 30, 2014 and December 31, 2013, is $4.9 million and $5.8 million, respectively, and is recorded in Other Assets.
	All significant intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.
	The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.
	These interim financial statements should be read in conjunction with the consolidated financial statements included in the Company's 2013 Annual Report on Form 10-K for the year ended December 31, 2013 (“the 2013 Form 10-K”) which should be consulted for a summary of the significant accounting policies utilized by the Company. These interim financial statements are prepared following accounting policies consistent with the Company's financial statements for the year ended December 31, 2013, except as noted below.

New_Accounting_Standards_and_A

New Accounting Standards and Accounting Changes	6 Months Ended
	Jun. 30, 2014
New Accounting Standards and Accounting Changes [Abstract]	'
New Accounting Standards and Accounting Changes	'
	2. New Accounting Standards and Accounting Changes
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contract with Customers (Topic 606)” (“ASU 2014-09”). The purpose of the amendment is to clarify the principles for recognizing revenue and developing common revenue standards between US GAAP and IFRS, through the application of a single comprehensive model for Company's to use in accounting for revenue arising from contracts with customers. Under this amended standard, the Company will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. For public entities, the amendments are effective for interim and annual reporting periods beginning after December 15, 2016. The Company is currently assessing the impact of ASU 2014-09 on its consolidated financial statements.
	The adoption of new accounting policies and recently issued FASB accounting standard codification updates, except for ASU No. 2014-09, were not material to the Company's condensed consolidated financial statements for the period ended June 30, 2014.

Financing_Receivables

Financing Receivables	6 Months Ended
	Jun. 30, 2014
Financing Receivables [Abstract]	'
Financing Receivables	'
	3. Financing Receivables
	Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of theater systems are as follows:
		June 30,		December 31,
		2014		2013
	Gross minimum lease payments receivable	$	16,447	$	17,475
	Unearned finance income		-2,746		-3,052
	Minimum lease payments receivable		13,701		14,423
	Accumulated allowance for uncollectible amounts		-965		-806
	Net investment in leases		12,736		13,617
	Gross financed sales receivables		126,994		129,398
	Unearned finance income		-34,368		-35,669
	Financed sales receivables		92,626		93,729
	Accumulated allowance for uncollectible amounts		-493		-236
	Net financed sales receivables		92,133		93,493
	Total financing receivables	$	104,869	$	107,110
	Net financed sales receivables due within one year	$	16,598	$	17,335
	Net financed sales receivables due after one year	$	75,535	$	76,158
	As at June 30, 2014, the financed sale receivables had a weighted average effective interest rate of 10.2% (December 31, 2013 — 9.8%).

Inventories

Inventories	6 Months Ended
	Jun. 30, 2014
Inventories [Abstract]	'
Inventories	'
	4. Inventories
		June 30,		December 31,
		2014		2013
	Raw materials	$	7,983	$	4,321
	Work-in-process		953		500
	Finished goods		7,828		5,004
		$	16,764	$	9,825
	At June 30, 2014, finished goods inventory for which title had passed to the customer and revenue was deferred amounted to $0.7 million (December 31, 2013 — $1.7 million).
	During the three and six months ended June 30, 2014, the Company had write-downs for excess and obsolete inventory based upon current estimates of net realizable value considering future events and conditions of less than $0.1 million and less than $0.1 million, respectively (2013 — $nil and $nil, respectively).

Property_Plant_and_Equipment

Property Plant and Equipment	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	5. Property, Plant and Equipment
			As at June 30, 2014
					Accumulated		Net Book
			Cost		Depreciation		Value
	Equipment leased or held for use
		Theater system components	$	166,796	$	57,542	$	109,254
		Camera equipment		5,442		2,921		2,521
				172,238		60,463		111,775
	Assets under construction			17,267		-		17,267
	Other property, plant and equipment
		Land		8,114		-		8,114
		Buildings		15,948		10,696		5,252
		Office and production equipment		28,237		20,363		7,874
		Leasehold improvements		9,924		9,387		537
				62,223		40,446		21,777
			$	251,728	$	100,909	$	150,819
			As at December 31, 2013
					Accumulated		Net Book
			Cost		Depreciation		Value
	Equipment leased or held for use
		Theater system components	$	158,192	$	51,537	$	106,655
		Camera equipment		4,591		2,736		1,855
				162,783		54,273		108,510
	Assets under construction			8,055		-		8,055
	Other property, plant and equipment
		Land		1,593		-		1,593
		Buildings		15,832		10,410		5,422
		Office and production equipment		27,190		18,707		8,483
		Leasehold improvements		9,884		9,100		784
				54,499		38,217		16,282
			$	225,337	$	92,490	$	132,847

Other_Intangible_Assets

Other Intangible Assets	6 Months Ended
	Jun. 30, 2014
Other Intangible Assets [Abstract]	'
Other Intangible Assets	'
	6. Other Intangible Assets
		As at June 30, 2014
				Accumulated		Net Book
		Cost		Amortization		Value
	Patents and trademarks	$	9,387	$	6,001	$	3,386
	Licenses and intellectual property		19,990		4,051		15,939
	Other		8,892		1,238		7,654
		$	38,269	$	11,290	$	26,979
		As at December 31, 2013
				Accumulated		Net Book
		Cost		Amortization		Value
	Patents and trademarks	$	8,774	$	5,741	$	3,033
	Licenses and intellectual property		19,950		3,260		16,690
	Other		8,843		821		8,022
		$	37,567	$	9,822	$	27,745
	Other intangible assets of $8.9 million are comprised mainly of the Company's investment in an enterprise resource planning system. Fully amortized other intangible assets are still in use by the Company.
	During the six months ended June 30, 2014, the Company acquired $0.5 million in other intangible assets. The weighted average amortization period for these additions was 10 years.
	During the three and six months ended June 30, 2014, the Company incurred costs of less than $0.1 million and less than $0.1 million, respectively, to renew or extend the term of acquired other intangible assets which were recorded in selling, general and administrative expenses (2013 – less than $0.1 million and $0.1 million, respectively).
	As at June 30, 2014, estimated amortization expense for each of the years ended December 31, are as follows:
	2014 (six months remaining)	$	1,468
	2015		2,833
	2016		2,654
	2017		2,654
	2018		2,654

Credit_Facility

Credit Facility	6 Months Ended
	Jun. 30, 2014
Credit Facility [Abstract]	'
Credit Facility	'
	7. Credit Facility
	On February 7, 2013, the Company amended and restated the terms of its existing senior secured credit facility (the “Prior Credit Facility”). The amended and restated facility (the “Credit Facility”), with a scheduled maturity of February 7, 2018, has a maximum borrowing capacity of $200.0 million. The Prior Credit Facility had a maximum borrowing capacity of $110.0 million. Certain of the Company's subsidiaries serve as guarantors (the “Guarantors”) of the Company's obligations under the Credit Facility. The Credit Facility is collateralized by a first priority security interest in substantially all of the present and future assets of the Company and the Guarantors. On March 14, 2014, the Company amended the terms of the Credit Facility (“Amendment No.1”) to obtain consents from the lenders named therein to allow it to enter into certain corporate transactions, including the sale of a 20.0% interest in IMAX China (Holding), Inc. (“IMAX China”).
	The terms of the Credit Facility are set forth in the Third Amended and Restated Credit Agreement (the “Credit Agreement”), dated February 7, 2013, among the Company, the Guarantors, the lenders named therein, Wells Fargo Bank, National Association (“Wells Fargo”), as agent and issuing lender (Wells Fargo, together with the lenders named therein, the “Lenders”) and Wells Fargo Securities, LLC, as Sole Lead Arranger and Sole Bookrunner and in various collateral and security documents entered into by the Company and the Guarantors. Each of the Guarantors has also entered into a guarantee in respect of the Company's obligations under the Credit Facility.
	Under the Credit Facility, the effective interest rate for the three and six months ended June 30, 2014 for the revolving loan portion was nil and nil, respectively, as no amounts were outstanding during the period (2013 – 2.19% and 2.40%, respectively).
	The Company was in compliance with all of these requirements at June 30, 2014.
	Total amounts drawn and available under the Credit Facility at June 30, 2014 were $nil and $200.0 million, respectively (December 31, 2013 — $nil and $200.0 million, respectively).
	Wells Fargo Foreign Exchange Facility
	Within the Credit Facility, the Company is able to purchase foreign currency forward contracts and/or other swap arrangements. There is no settlement risk on its foreign currency forward contracts at June 30, 2014 as the fair value exceeded the notional value of the forward contracts. As at June 30, 2014, the Company has $23.5 million of such arrangements outstanding.
	Bank of Montreal Facility
	As at June 30, 2014, the Company has available a $10.0 million facility (December 31, 2013 — $10.0 million) with the Bank of Montreal for use solely in conjunction with the issuance of performance guarantees and letters of credit fully insured by EDC (the “Bank of Montreal Facility”). As at June 30, 2014, the Company has letters of credit and advance payment guarantees outstanding of $0.3 million (December 31, 2013 — $0.3 million) under the Bank of Montreal Facility.

Commitments

Commitments	6 Months Ended
	Jun. 30, 2014
Commitments, Contingencies and Guarantees [Abstract]	'
Commitments	'
	8. Commitments
	As at June 30, 2014, the Company's committed investment for the construction of the new Los Angeles-area office facility in Playa Vista is approximately $45.0 to $50.0 million, of which $14.7 million has been capitalized to-date. The Company anticipates that construction of the new Playa Vista facility will be completed in 2015. A significant portion of the project is expected to be financed through a construction loan and related term facility.

Contingencies_and_Guarantees

Contingencies and Guarantees	6 Months Ended
	Jun. 30, 2014
Commitments, Contingencies and Guarantees [Abstract]	'
Contingencies and Guarantees	'
	9. Contingencies and Guarantees
	The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. In accordance with the Contingencies Topic of the FASB ASC, the Company will make a provision for a liability when it is both probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has adequate provisions for any such matters. The Company reviews these provisions in conjunction with any related provisions on assets related to the claims at least quarterly and adjusts these provisions to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other pertinent information related to the case. Should developments in any of these matters outlined below cause a change in the Company's determination as to an unfavorable outcome and result in the need to recognize a material provision, or, should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on the Company's results of operations, cash flows, and financial position in the period or periods in which such a change in determination, settlement or judgment occurs.
	The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.
	(a) In March 2005, the Company, together with Three-Dimensional Media Group, Ltd. (“3DMG”), filed a complaint in the U.S. District Court for the Central District of California, Western Division, against In-Three, Inc. (“In-Three”) alleging patent infringement. On March 10, 2006, the Company and In-Three entered into a settlement agreement settling the dispute between the Company and In-Three. Despite the settlement reached between the Company and In-Three, co-plaintiff 3DMG refused to dismiss its claims against In-Three. Accordingly, the Company and In-Three moved jointly for a motion to dismiss the Company's and In-Three's claims. On August 24, 2010, the Court dismissed all of the claims pending between the Company and In-Three, thus dismissing the Company from the litigation.
	On May 15, 2006, the Company initiated arbitration against 3DMG before the International Centre for Dispute Resolution in New York (the “ICDR”), alleging breaches of the license and consulting agreements between the Company and 3DMG. On June 15, 2006, 3DMG filed an answer denying any breaches and asserting counterclaims that the Company breached the parties' license agreement. On June 21, 2007, the ICDR unanimously denied 3DMG's Motion for Summary Judgment filed on April 11, 2007 concerning the Company's claims and 3DMG's counterclaims. The proceeding was suspended on May 4, 2009 due to failure of 3DMG to pay fees associated with the proceeding. The proceeding was further suspended on October 11, 2010 pending resolution of reexamination proceedings currently pending involving one of 3DMG's patents. The Company will continue to pursue its claims vigorously and believes that all allegations made by 3DMG are without merit. The Company further believes that the amount of loss, if any, suffered in connection with the counterclaims would not have a material impact on the financial position or results of operations of the Company, although no assurance can be given with respect to the ultimate outcome of the arbitration.
	(b) In January 2004, the Company and IMAX Theatre Services Ltd., a subsidiary of the Company, commenced an arbitration seeking damages before the International Court of Arbitration of the International Chambers of Commerce (the “ICC”) with respect to the breach by Electronic Media Limited (“EML”) of its December 2000 agreement with the Company. In June 2004, the Company commenced a related arbitration before the ICC against EML's affiliate, E-City Entertainment (I) PVT Limited (“E-City”). On March 27, 2008, the arbitration panel issued a final award in favor of the Company in the amount of $11.3 million, consisting of past and future rents owed to the Company, plus interest and costs, as well as an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid. In July 2008, E-City commenced a proceeding in Mumbai, India seeking an order that the ICC award may not be recognized in India. The Company has opposed that application on a number of grounds and seeks to have the ICC award recognized in India. On June 24, 2011, the Company commenced an application to the Ontario Superior Court of Justice for recognition of the final award. On December 2, 2011, the Ontario court issued an order recognizing the final award and requiring E-City to pay the Company $30,000 to cover the costs of the application. On January 18, 2012, the Company filed an application in New York State Supreme Court seeking recognition of the Ontario order in New York. E-City did not appear in that proceeding and on April 11, 2012, the New York court issued an order granting the Company's application leading to an entry of $15.5 million default judgment in favor of the Company on May 4, 2012. On March 11, 2014, E-City moved the Court to vacate this judgment on the ground that the service of process was improper, and that motion was granted by order dated July 3, 2014.  The Company intends to appeal that order and/or to commence a new proceeding to have the Canadian judgment recognized in New York.  On January 30, 2013, the Company filed another action in the New York Supreme Court seeking to collect the amount due under the New York judgment from certain entities and individuals affiliated with E-City. On June 13, 2013, the Bombay High Court ruled that it has jurisdiction over the proceeding but on November 19, 2013, the Supreme Court of India stayed proceedings in the High Court pending Supreme Court review of the High Court's ruling. The Respondents in the New York action have answered and objected to the Company's petition, and they have moved to dismiss for improper service of process.  The New York Court heard oral arguments on August 20, 2013 and April 3, 2014 and has not yet issued a decision. On July 11, 2014, the Company moved to amend its petition to have the Canadian judgment recognized as part of this proceeding.
	(c) The Company and certain of its officers and directors were named as defendants in eight purported class action lawsuits filed between August 11, 2006 and September 18, 2006, alleging violations of U.S. federal securities laws. These eight actions were filed in the U.S. District Court for the Southern District of New York (the “Court”). On January 18, 2007, the Court consolidated all eight class action lawsuits and appointed Westchester Capital Management, Inc. as the lead plaintiff and Abbey Spanier Rodd & Abrams, LLP as lead plaintiff's counsel. On October 2, 2007, plaintiffs filed a consolidated amended class action complaint. The amended complaint, brought on behalf of shareholders who purchased the Company's common stock on the NASDAQ between February 27, 2003 and July 20, 2007 (the “U.S. Class”), alleges primarily that the defendants engaged in securities fraud by disseminating materially false and misleading statements during the class period regarding the Company's revenue recognition of theater system installations, and failing to disclose material information concerning the Company's revenue recognition practices. The amended complaint also added PricewaterhouseCoopers LLP, the Company's auditors, as a defendant. On April 14, 2011, the Court issued an order appointing The Merger Fund as the lead plaintiff and Abbey Spanier Rodd & Abrams, LLP as lead plaintiff's counsel. On November 2, 2011, the parties entered into a memorandum of understanding containing the terms and conditions of a settlement of this action. On January 26, 2012, the parties executed and filed with the Court a formal stipulation of settlement and proposed form of notice to the class, which the Court preliminarily approved on February 1, 2012. Under the terms of the settlement, members of the U.S. Class who did not opt out of the settlement will release defendants from liability for all claims that were alleged in this action or could have been alleged in this action or any other proceeding (including the action in Canada as described in (d) of this note (the “Canadian Action”) relating to the purchase of IMAX securities on the NASDAQ from February 27, 2003 and July 20, 2007 or the subject matter and facts relating to this action. As part of the settlement and in exchange for the release, defendants will pay $12.0 million to a settlement fund which amount will be funded by the carriers of the Company's directors and officers insurance policy and by PricewaterhouseCoopers LLP. On March 26, 2012, the parties executed and filed with the Court an amended formal stipulation of settlement and proposed form of notice to the class, which the court preliminarily approved on March 28, 2012. On June 20, 2012, the Court issued an order granting final approval of the settlement. The settlement was distributed to the U.S. Class on May 5, 2014.
	(d) A class action lawsuit was filed on September 20, 2006 in the Canadian Court against the Company and certain of its officers and directors, alleging violations of Canadian securities laws. This lawsuit was brought on behalf of shareholders who acquired the Company's securities between February 17, 2006 and August 9, 2006. The lawsuit seeks $210.0 million in compensatory and punitive damages, as well as costs. For reasons released December 14, 2009, the Canadian Court granted leave to the plaintiffs to amend their statement of claim to plead certain claims pursuant to the Securities Act (Ontario) against the Company and certain individuals (“the Defendants”) and granted certification of the action as a class proceeding. These are procedural decisions, and do not contain any conclusions binding on a judge at trial as to the factual or legal merits of the claim. Leave to appeal those decisions was denied. In March 2013, the Defendants obtained an Order enforcing the settlement Order in the parallel class action in the United States in this Canadian class action lawsuit, with the result that the class in this case was reduced in size by approximately 85%.  A motion by the Plaintiffs for leave to appeal that Order was dismissed.  The Company believes the allegations made against it in the statement of claim are meritless and will vigorously defend the matter, although no assurance can be given with respect to the ultimate outcome of such proceedings. The Company's directors' and officers' insurance policy provides for reimbursement of costs and expenses incurred in connection with this lawsuit as well as potential damages awarded, if any, subject to certain policy limits, exclusions and deductibles.
	(e) On June 26, 2013, the Company filed suit against GDC Technology (USA) LLC and certain of its affiliates (collectively, “GDC”) in the U.S. District Court for the Central District of California alleging trade secret misappropriation, unjust enrichment and unfair competition and seeking injunctive relief, compensatory damages, and punitive damages. This action is based on GDC's commercial exploitation of large format digital theater projection system and film conversion technologies, which the lawsuit alleged were stolen from the Company by its former employee, Gary Tsui, and then provided by Tsui to various technology companies in China. The Company's action against GDC alleged that GDC knowingly and actively used these trade secrets and marketing large format film projection systems and conversion technology that the Company was informed and believes were derived from and incorporate the trade secrets stolen by Tsui. On June 20, 2014, following the entry by the Company and GDC into a confidential settlement agreement, the Company dismissed the lawsuit against GDC without prejudice.
	(f) The Company is also involved in litigation against Gary Tsui (“Tsui”) and related parties in both Canada and China based on Tsui's theft and use of the Company's trade secrets. The Company filed a lawsuit against Tsui and other related individuals and entities in the Ontario Superior Court of Justice on December 8, 2009, through which the Company sought injunctive relief to prohibit Tsui from disclosing or using the Company's confidential and proprietary information and from competing with the Company. The Company is also seeking compensatory and punitive damages. The Ontario Court awarded the injunctive relief sought by the Company on December 22, 2009. On April 30, 2013, a warrant was issued for Tsui's arrest based on his refusal to comply with the orders of the Ontario court, including with respect to the continued use of the Company's trade secrets. The Ontario action was heard in June 2014 and judgment was rendered in the Company's favor.  The Court awarded the Company $6.0 million in damages against all defendants for conversion and misuse of confidential information, $456,000 against all defendants for disgorgement of profits from the lost business opportunity, $50,000 from Tsui in punitive damages of prejudgment interest on the forgoing and $300,000 in costs against all defendants.  The Company also initiated suits against Tsui in Beijing No. 1 Intermediate People's Court in Beijing, China on February 16, 2013 and December 3, 2013, seeking relief similar to that sought in the Ontario action. In October, 2013, Jiangsu Sunway Digital Technology Co. Ltd (a company incorporated by Tsui), commenced an action against the Company in Zhenjiang Intermediate People's Court, in Zhenjiang, China, alleging that the Company defamed and slandered the plaintiff through the commencement of the actions against Tsui in Canada  and China referred to above, as well as several written communications to third parties. The plaintiff claims damages in the preliminary amount of 6.0 million Chinese Yuan Renminbi plus costs. The Company is vigorously defending  this action. The actions in China remain ongoing.
	(g) In March 2013, IMAX (Shanghai) Multimedia Technology Co., Ltd., the Company's wholly-owned subsidiary in China, received notice from the Shanghai office of the General Administration of Customs that it had been selected for a customs audit. The Company is unable to assess the potential impact, if any, of the audit at this time.
	(h) In addition to the matters described above, the Company is currently involved in other legal proceedings or governmental inquiries which, in the opinion of the Company's management, will not materially affect the Company's financial position or future operating results, although no assurance can be given with respect to the ultimate outcome of any such proceedings.
	(i) In the normal course of business, the Company enters into agreements that may contain features that meet the definition of a guarantee. The Guarantees Topic of the FASB ASC defines a guarantee to be a contract (including an indemnity) that contingently requires the Company to make payments (either in cash, financial instruments, other assets, shares of its stock or provision of services) to a third party based on (a) changes in an underlying interest rate, foreign exchange rate, equity or commodity instrument, index or other variable, that is related to an asset, a liability or an equity security of the counterparty, (b) failure of another party to perform under an obligating agreement or (c) failure of another third party to pay its indebtedness when due.
	Financial Guarantees
	The Company has provided no significant financial guarantees to third parties.
	Product Warranties
	The following summarizes the accrual for product warranties that was recorded as part of accrued liabilities in the condensed consolidated balance sheets:
		June 30,		December 31,
		2014		2013
	Balance at the beginning of period	$	7	$	32
	Warranty redemptions		-5		-77
	Warranties issued		5		52
	Balance at the end of period	$	7	$	7
	Director/Officer Indemnifications
	The Company's General By-law contains an indemnification of its directors/officers, former directors/officers and persons who have acted at its request to be a director/officer of an entity in which the Company is a shareholder or creditor, to indemnify them, to the extent permitted by the Canada Business Corporations Act, against expenses (including legal fees), judgments, fines and any amount actually and reasonably incurred by them in connection with any action, suit or proceeding in which the directors and/or officers are sued as a result of their service, if they acted honestly and in good faith with a view to the best interests of the Company. The nature of the indemnification prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. The Company has purchased directors' and officers' liability insurance. No amount has been accrued in the condensed consolidated balance sheets as at March 31, 2014 and December 31, 2013 with respect to this indemnity.
	Other Indemnification Agreements
	In the normal course of the Company's operations, the Company provides indemnifications to counterparties in transactions such as: theater system lease and sale agreements and the supervision of installation or servicing of the theater systems; film production, exhibition and distribution agreements; real property lease agreements; and employment agreements. These indemnification agreements require the Company to compensate the counterparties for costs incurred as a result of litigation claims that may be suffered by the counterparty as a consequence of the transaction or the Company's breach or non-performance under these agreements. While the terms of these indemnification agreements vary based upon the contract, they normally extend for the life of the agreements. A small number of agreements do not provide for any limit on the maximum potential amount of indemnification; however, virtually all of the Company's system lease and sale agreements limit such maximum potential liability to the purchase price of the system. The fact that the maximum potential amount of indemnification required by the Company is not specified in some cases prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. Historically, the Company has not made any significant payments under such indemnifications and no amounts have been accrued in the condensed consolidated financial statements with respect to the contingent aspect of these indemnities.

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Operations Supplemental Information	6 Months Ended
	Jun. 30, 2014
Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]	'
Condensed Consolidated Statements of Operations Supplemental Information	'
	10. Condensed Consolidated Statements of Operations Supplemental Information
	(a)  Selling Expenses
	The Company defers direct selling costs such as sales commissions and other amounts related to its sale and sales-type lease arrangements until the related revenue is recognized. These costs and direct advertising and marketing, included in costs and expenses applicable to revenues-equipment and product sales, totaled $0.7 million and $0.9 million for the three and six months ended June 30, 2014, respectively (2013 — $0.4 million and $0.7 million, respectively).
	Film exploitation costs, including advertising and marketing, totaled $2.2 million and $3.6 million for the three and six months ended June 30, 2014, respectively (2013 — $1.4 million and $2.4 million, respectively) and are recorded in costs and expenses applicable to revenues-services as incurred.
	Commissions are recognized as costs and expenses applicable to revenues-rentals in the month they are earned. These costs totaled $0.5 million and $0.5 million for the three and six months ended June 30, 2014, respectively (2013 — $0.5 million and $0.5 million, respectively). Direct advertising and marketing costs for each theater are charged to costs and expenses applicable to revenues-rentals as incurred. These costs totaled $0.5 million and $0.7 million for the three and six months ended June 30, 2014, respectively (2013 — $0.5 million and $0.7 million, respectively).
	(b)  Foreign Exchange
	Included in selling, general and administrative expenses for the three and six months ended June 30, 2014 is a gain of $0.7 million and a gain of less than $0.1 million, respectively, for net foreign exchange gains/losses related to the translation of foreign currency denominated monetary assets and liabilities. See note 17(d) for additional information.
	(c)  Collaborative Arrangements
	Joint Revenue Sharing Arrangements
	In a joint revenue sharing arrangement, the Company receives a portion of a theater's box-office and concession revenues and in some cases a small upfront or initial payment, in exchange for placing a theater system at the theater operator's venue. Under joint revenue sharing arrangements, the customer has the right and the ability to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company's joint revenue sharing arrangements are typically non-cancellable for 10 to 13 years with renewal provisions. Title to equipment under joint revenue sharing arrangements does not transfer to the customer. The Company's joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement's shipping terms and ending on the date the theater systems are delivered back to the Company.
	The Company has signed joint revenue sharing agreements with 39 exhibitors for a total of 654 theater systems, of which 408 theaters were operating as of June 30, 2014. The terms of the Company's joint revenue sharing arrangements are similar in nature, rights and obligations. The accounting policy for the Company's joint revenue sharing arrangements is disclosed in note 2(m) of the Company's 2013 Form 10-K.
	Amounts attributable to transactions arising between the Company and its customers under joint revenue sharing arrangements are included in Rentals revenue and for the three and six months ended June 30, 2014 amounted to $19.4 million and $30.2 million, respectively (2013 — $18.3 million and $27.7 million, respectively).
	IMAX DMR
	In an IMAX DMR arrangement, the Company transforms conventional motion pictures into the Company's large screen format, allowing the release of Hollywood content to the global IMAX theater network. In a typical IMAX DMR film arrangement, the Company will absorb its costs for the digital re-mastering and then recoup this cost from a percentage of the gross box-office receipts of the film, which generally range from 10-15%. The Company does not typically hold distribution rights or the copyright to these films.
	For the six months ended June 30, 2014, the majority of IMAX DMR revenue was earned from the exhibition of 26 IMAX DMR films were exhibited throughout the IMAX theater network. The Company has entered into arrangements with film producers to convert 9 additional films, which are expected to be released during the remainder of 2014, the terms of which are substantially similar in nature, rights and obligations. The accounting policy for the Company's IMAX DMR arrangements is disclosed in note 2(m) of the Company's 2013 Form 10-K.
	Amounts attributable to transactions arising between the Company and its customers under IMAX DMR arrangements are included in Services revenue and for the three and six months ended June 30, 2014 amounted to $24.0 million and $39.2 million, respectively (2013 — $26.0 million and $40.3 million, respectively).
	Co-Produced Film Arrangements
	In certain film arrangements, the Company co-produces a film with a third party whereby the third party retains the copyright and rights to the film, except that the Company obtains exclusive theatrical distribution rights to the film. Under these arrangements, both parties contribute funding to the Company's wholly-owned production company for the production of the film and for associated exploitation costs. Clauses in the film arrangements generally provide for the third party to take over the production of the film if the cost of the production exceeds its approved budget or if it appears as though the film will not be delivered on a timely basis.
	The accounting policies relating to co-produced film arrangements are disclosed in notes 2(a) and 2(m) of the Company's 2013 Form 10-K.
	At June 30, 2014, the Company has one significant co-produced film arrangement which represents the VIE total assets and liabilities balance of $0.5 million and 6 other co-produced film arrangements, the terms of which are similar.
	For the three and six months ended June 30, 2014, amounts totaling $1.3 million and $1.9 million, respectively (2013 — $1.0 million and $2.1 million, respectively) attributable to transactions between the Company and other parties involved in the production of the films have been included in cost and expenses applicable to revenues-services.

Condensed_Consolidated_Stateme5

Condensed Consolidated Statements of Cash Flows Supplemental Information	6 Months Ended
	Jun. 30, 2014
Condensed Consolidated Statements of Cash Flows Supplemental Information [Abstract]	'
Condensed Consolidated Statements of Cash Flows Supplemental Information	'
	11. Condensed Consolidated Statements of Cash Flows Supplemental Information
	(a) Changes in other non-cash operating assets and liabilities are comprised of the following:
			Six Months
			Ended June 30,
			2014		2013
	(Increase) decrease in:
		Accounts receivable	$	-398	$	-20,661
		Financing receivables		2,074		-5,994
		Inventories		-7,012		-1,717
		Prepaid expenses		-842		-739
		Commissions and other deferred selling expenses		-686		-131
		Insurance recoveries		10,958		112
		Other assets		-602		-74
	Increase (decrease) in:
		Accounts payable		-6,908		4,132
		Accrued and other liabilities(1)		-11,005		109
		Deferred revenue		11,202		-38
			$	-3,219	$	-25,001
	__________
	(1)       Change in accrued and other liabilities for the six months ended June 30, 2014 includes payments of $nil for variable stock-based compensation (2013 - $1.0 million).
		(b) Cash payments made on account of:
			Six Months
			Ended June 30,
			2014		2013
	Income taxes		$	3,729	$	301
	Interest		$	-	$	347
		(c) Depreciation and amortization are comprised of the following:
			Six Months
			Ended June 30,
				2014		2013
	Film assets		$	5,343	$	10,020
	Property, plant and equipment
		Joint revenue sharing arrangements		5,852		5,819
		Other property, plant and equipment		2,676		2,454
	Other intangible assets			1,468		1,397
	Other assets			343		286
	Deferred financing costs			263		225
			$	15,945	$	20,201
		(d) Write-downs, net of recoveries, are comprised of the following:
			Six Months
			Ended June 30,
				2014		2013
	Impairment of available-for-sale investment		$	650	$	-
	Accounts receivable			449		-45
	Financing receivables			167		100
	Property, plant and equipment			270		-
	Inventories			43		-
			$	1,579	$	55

Receivable_Provisions_Net_of_R

Receivable Provisions Net of Recoveries	6 Months Ended
	Jun. 30, 2014
Receivable Provisions, Net of Recoveries [Abstract]	'
Receivable Provisions, Net of Recoveries	'
	12. Receivable Provisions, Net of Recoveries
	The following table reflects the Company's receivable provisions net of recoveries recorded in the condensed consolidated statements of operations:
		Three Months				Six Months
		Ended June 30,				Ended June 30,
		2014		2013		2014		2013
	Accounts receivable provisions, net of recoveries	$	329	$	-45	$	449	$	-45
	Financing receivables, net of recoveries		-		100		167		100
	Receivable provisions, net of recoveries	$	329	$	55	$	616	$	55

Income_Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Taxes [Abstract]	'
Income Taxes	'
	13. Income Taxes
	(a)       Income Taxes
	The Company's effective tax rate differs from the statutory tax rate and varies from year to year primarily as a result of permanent differences, investment and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted statutory tax rate increases or reductions in the year, changes due to foreign exchange, changes in the Company's valuation allowance based on the Company's recoverability assessments of deferred tax assets, and favorable or unfavorable resolution of various tax examinations. During the six months ended June 30, 2014, there was no change in the Company's estimates of the recoverability of its deferred tax assets based on an analysis of both positive and negative evidence including projected future earnings.
	As at June 30, 2014, the Company had net deferred income tax assets after valuation allowance of $21.2 million (December 31, 2013 — $24.3 million), which consists of a gross deferred income tax asset of $26.0 million (December 31, 2013 — $29.1 million), against which the Company is carrying a $4.8 million valuation allowance (December 31, 2013 — $4.8 million).
	(b)       Income Tax Effect on Comprehensive Income
	The income tax (expense) benefit related to the following items included in the Company's other comprehensive income (loss) are:
		Three Months				Six Months
		Ended June 30,				Ended June 30,
		2014		2013		2014		2013
	Unrealized change in cash flow hedging instruments	$	-242	$	129	$	-159	$	206
	Realized change in cash flow hedging instruments upon settlement		-66		-22		-1		11
	Other-than-temporary impairment of available-for-sale investment		-45		-		-45		-
	Foreign currency translation adjustments		7		-61		40		26
	Amortization of actuarial loss on defined benefit plan		-		-29		-		-58
	Gain on curtailment of postretirement benefit plan		-		-		-		-100
		$	-346	$	17	$	-165	$	85

Capital_Stock

Capital Stock	6 Months Ended
	Jun. 30, 2014
Capital Stock [Abstract]	'
Capital Stock	'
	14. Capital Stock
	(a)  Stock-Based Compensation
	The compensation costs recorded in the condensed consolidated statement of operations for these plans were $4.7 million and $7.9 million for the three and six months ended June 30, 2014, respectively (2013 — $3.1 million and $5.9 million, respectively).
	As at June 30, 2014, the Company has reserved a total of 9,887,137 (December 31, 2013 — 10,530,723) common shares for future issuance under the Company's Stock Option Plan (“SOP”) and the IMAX 2013 Long-Term Incentive Plan (“IMAX LTIP”). Of the common shares reserved for issuance, there are options in respect of 6,552,500 common shares and RSUs in respect of 642,116 common shares outstanding at June 30, 2014. At June 30, 2014, options in respect of 3,656,730 common shares were vested and exercisable.
	Stock Option Plan
	The Company recorded an expense of $2.2 million and $4.4 million for the three and six months ended June 30, 2014, respectively (2013 — $2.2 million and $4.4 million, respectively), related to stock option grants issued to employees and directors in the IMAX LTIP and SOP plans. An income tax benefit is recorded in the condensed consolidated statements of operations of $0.9 million for these costs.
	The weighted average fair value of all stock options, granted to employees and directors for the three and six months ended June 30, 2014 at the grant date was not applicable and $8.33 per share, respectively (2013 — $6.51 per share and $6.54 per share, respectively). The following assumptions were used to estimate the average fair value of the stock options:
			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Average risk-free interest rate		n/a		1.10%		2.50%		1.34%
	Expected option life (in years)		n/a		4.63		4.48 - 5.82		4.62 - 4.63
	Expected volatility		n/a		40%		37.50%		40%
	Annual termination probability		n/a		8.46% - 8.52%		0% - 8.40%		8.46% - 8.52%
	Dividend yield		n/a		0%		0%		0%
	Stock options to Non-Employees
	No stock options were granted to non-employees in 2014.
	During the three and six months ended June 30, 2013, an aggregate of 2,500 stock options to purchase the Company's common stock with an average exercise price of $26.28 were granted to certain advisors and strategic partners of the Company. These stock options granted have a maximum contractual life of 7 years. The stock options granted in 2013 were granted under the IMAX LTIP.
	As at June 30, 2014, non-employee stock options outstanding amounted to 54,251 stock options (2013 — 108,001) with a weighted average exercise price of $13.71 (2013 — $14.08). 41,576 stock options (2013 — 41,384) were exercisable with an average weighted exercise price of $11.15 (2013 — $11.36) and the vested stock options have an aggregate intrinsic value of $0.7 million (2013 — $0.6 million). The weighted average fair value of stock options granted to non-employees during the three and six months ended June 30, 2013 at the measurement date was $11.50 per share, utilizing a Binomial Model with the following underlying assumptions:
			Three Months				Six Months
			Ended June 30,				Ended June 30,
			2014		2013		2014		2013
	Average risk-free interest rate		n/a		1.64%		n/a		1.64%
	Contractual option life		n/a		7 Years		n/a		7 Years
	Average expected volatility		n/a		40%		n/a		40%
	Dividend yield		n/a		0%		n/a		0%
	For the three and six months ended June 30, 2014, the Company recorded a charge of less than $0.1 million, respectively (2013 — $0.1 million, respectively) to cost and expenses related to revenues − services and selling, general and administrative expenses related to the non-employee stock options. Included in accrued liabilities is an accrual of less than $0.1 million for non-employee stock options (December 31, 2013 − $0.1 million).
	China Long Term Incentive Plan (“China LTIP”)
	Each stock option issued under the China LTIP represents an opportunity to participate economically in the future growth and value creation of the subsidiary. The China LTIP options issued by the subsidiary (“China Options”) operate in tandem with options granted to certain employees of the subsidiary under the Company's SOP and IMAX LTIP (“Tandem Options”).
	In 2012, an aggregate of 146,623 Tandem Options were granted to certain employees in conjunction with China Options with an average price of $22.39 per share in accordance with the China LTIP. During the three and six months ended June 30, 2014, an additional nil and 6,021, respectively, Tandem Options were granted in conjunction with China Options with an average price of $nil and $27.20 per share, respectively. The Tandem Options have a maximum contractual life of 7 years. As at June 30, 2014, there were 152,644 (December 31, 2013 — 146,623) outstanding and unvested Tandem Options issued under the China LTIP with a weighted average exercise price of $22.58 per share (December 31, 2013 — $22.39 per share). The weighted average fair value of the Tandem Options granted during the three and six months ended June 30, 2014 was n/a and $7.02 per share, respectively. The total fair value of the Tandem Options granted with respect to the China LTIP was $1.6 million. The Company is recognizing this expense over a 5 year period. If a performance event occurs, including upon the occurrence of a qualified initial public offering or upon a change in control on or prior to the fifth anniversary of the grant date, the 152,644 Tandem Options issued forfeit immediately and the related charge would be reversed. There were no option awards issued under the China LTIP during the three and six months ended June 30, 2013.
	The Company has recorded an expense of $0.1 million and $0.2 million for the three and six months ended June 30, 2014 (June 30, 2013 — $0.1 million and $0.l million, respectively) related to Tandem Options issued under the China LTIP.
	Stock Option Summary
	The following table summarizes certain information in respect of option activity under the SOP and IMAX LTIP for the six month periods ended June 30:
								Weighted Average Exercise
			Number of Shares					Price Per Share
			2014		2013		2014			2013
	Options outstanding, beginning of period		6,263,121		7,441,068		$	21.11		$	18.48
	Granted		828,353		192,112			27.44			25.46
	Exercised		-505,187		-579,681			5.26			6.89
	Forfeited		-10,000		-69,658			18.98			26.58
	Cancelled		-23,787		-1,550			33.6			28.78
	Options outstanding, end of period		6,552,500		6,982,291			23.09			19.56
	Options exercisable, end of period		3,656,730		3,477,935			21.35			17.17
	The Company cancelled 17,787 and 23,787 stock options from its SOP (2013 — 300 and 1,550, respectively) surrendered by Company employees during the three and six months ended June 30, 2014, respectively.
	As at June 30, 2014, 6,201,893 options were fully vested or are expected to vest with a weighted average exercise price of $22.96, aggregate intrinsic value of $37.1 million and weighted average remaining contractual life of 4.8 years. As at June 30, 2014, options that are exercisable have an intrinsic value of $27.7 million and a weighted average remaining contractual life of 4.5 years. The intrinsic value of options exercised in the three and six months ended June 30, 2014 was $9.0 million and $11.1 million, respectively (2013 — $3.8 million and $11.0 million, respectively).
	Restricted Share Units
	RSUs have been granted to employees, consultants and directors under the IMAX LTIP. Each RSU represents a contingent right to receive one common share and is the economic equivalent of one common share. The grant date fair value of each RSU is equal to the share price of the Company's stock at the grant date. The Company recorded an expense of $2.4 million and $3.3 million for the three and six month period ended June 30, 2014, respectively (2013 — $1.1 million and $1.1 million, respectively), related to RSU grants issued to employees and directors in the plan. The annual termination probability assumed for the three and six months ended June 30, 2014, was 0% and ranged from 0% to 9.46%, respectively. In addition, the Company recorded an expense of less than $0.1 million and less than $0.1 million for the three and six months ended June 30, 2014, respectively (2013 — less than $0.1 million and less than $0.1 million, respectively), related to RSU grants issued to certain advisors and strategic partners of the Company.
	During the three and six month period ended June 30, 2014, in connection with the vesting of RSUs, the Company delivered 61,386 and 104,524, respectively, Common Shares to IMAX LTIP participants, of which 76,708 Common Shares were issued from treasury and 27,816 Common Shares were purchased in the open market by the IMAX LTIP trustee.
	Total stock-based compensation expense related to non-vested RSU's not yet recognized at June 30, 2014 and the weighted average period over which the awards are expected to be recognized is $13.4 million and 3.1 years. The Company's actual tax benefits realized for the tax deductions related to the vesting of RSUs was $0.2 million and $0.5 million, respectively for the three and six months ended June 30, 2014.
	RSUs granted under the IMAX LTIP vest between one and four years from the date granted. Vesting of the RSUs is subject to continued employment or service with the Company.
	The following table summarizes certain information in respect of RSU activity under the IMAX LTIP for the six months ended June 30, 2014:
			Number of Awards				Weighted Average Grant Date Fair Value Per Share
			2014		2013		2014			2013
	RSUs outstanding, beginning of period		264,140		-		$	26.14		$	-
	Granted		482,588		277,198			27.41			26.28
	Vested and settled		-104,612		-39,761			26.13			26.28
	RSUs outstanding, end of period		642,116		237,437			27.09			26.28
	Stock Appreciation Rights
	There have been no stock appreciation rights (“SARs”) granted since 2007. As at June 30, 2014 and December 31, 2013, no SARS were outstanding. For the three and six months ended June 30, 2013, nil and 50,000 SARs were cash settled for $nil and $1.0 million, respectively. The average exercise price for the settled SARs for the three and six months ended June 30, 2013 was $nil and $6.86 per SAR. None of the SARs were forfeited, cancelled, or expired for the three and six months ended June 30, 2013. The Company recorded a recovery of $0.1 million and an expense of $0.3 million for the three and six months ended June 30, 2013, respectively, to selling, general and administrative expenses related to these SARs.
	(b)  Income Per Share
	Reconciliations of the numerator and denominator of the basic and diluted per-share computations are comprised of the following:
			Three Months							Six Months
			Ended June 30,							Ended June 30,
			2014			2013			2014			2013
Net income attributable to Common Shareholders		$	13,307		$	11,816		$	13,886		$	14,677
Less: Accretion charges associated with redeemable common stock			-142			-			-142			-
Net income applicable to Common Shareholders		$	13,165		$	11,816		$	13,744		$	14,677
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period			67,957			66,866			67,841			66,482
Weighted average number of shares issued during the period			271			86			227			317
Weighted average number of shares used in computing basic income per share			68,228			66,952			68,068			66,799
Assumed exercise of stock options and RSUs, net of shares assumed repurchased			1,224			1,941			1,380			1,970
Weighted average number of shares used in computing diluted income per share			69,452			68,893			69,448			68,769
The calculation of diluted earnings per share excludes 4,325,037 and 4,205,083 shares, respectively that are issuable upon exercise of 119,954 and nil RSUs, respectively and stock options of 4,205,083, respectively, for the three and six months ended June 30, 2014, as the impact of these exercises would be antidilutive.
(c)  Shareholders' Equity
The following summarizes the movement of Shareholders' Equity for the six months ended June 30, 2014:
Balance as at December 31, 2013			$	319,585
Net income attributable to Common Shareholders				13,886
Adjustments to capital stock:
	Cash received from issuance of common shares			2,657
	Issuance of common shares for vested RSUs			2,000
	Fair value of stock options exercised at date of grant			641
Adjustments to other equity:
	Employee stock options granted			4,540
	Non-employee stock options granted			149
	Fair value of stock options exercised at date of grant			-641
	RSUs granted			3,335
	RSUs vested			-2,792
	Excess tax benefits from RSUs			13
Adjustment for accretion charges associated with redeemable common stock				-142
Adjustments to accumulated other comprehensive loss:
	Unrealized net gain from cash flow hedging instruments			127
	Realization of cash flow hedging net loss upon settlement			504
	Other-than-temporary impairment of available-for-sale investment			350
	Foreign currency translation adjustments			-175
	Tax effect of movement in other comprehensive income			-165
Balance as at June 30, 2014			$	343,872

Segmented_Information

Segmented Information	6 Months Ended
	Jun. 30, 2014
Segmented Information [Abstract]	'
Segmented Information	'
	15. Segmented Information
	The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment. The theater system maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment provides IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment produces films and performs film re-mastering services. The film distribution segment distributes films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The Company refers to all theaters using the IMAX theater system as “IMAX theaters”. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items. The accounting policies of the segments are the same as those described in note 2 to the audited consolidated financial statements included in the Company's 2013 Form 10-K.
	Management, including the Company's Chief Executive Officer (“CEO”) who is the Company's Chief Operating Decision Maker (as defined in the Segment Reporting Topic of the FASB ASC), assesses segment performance based on segment revenues, gross margins and film performance. Selling, general and administrative expenses, research and development costs, amortization of intangibles, receivables provisions (recoveries), write-downs net of recoveries, interest income, interest expense and tax (provision) recovery are not allocated to the segments.
	Transactions between the film production and IMAX DMR segment and the film post-production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.
	Transactions among the other segments are not significant.
			Three Months						Six Months
			Ended June 30,						Ended June 30,
				2014			2013		2014			2013
	Revenue(1)
	IMAX theater systems
		IMAX systems	$	17,996		$	20,792		$	25,756		$	33,530
		Theater system maintenance		8,673			7,952			16,868			15,741
		Joint revenue sharing arrangements		19,363			18,336			30,219			27,712
				46,032			47,080			72,843			76,983
	Films
		Production and IMAX DMR		24,050			25,952			39,235			40,307
		Distribution		2,942			2,185			4,405			4,672
		Post-production		2,391			2,927			5,617			4,068
				29,383			31,064			49,257			49,047
	Other			3,730			3,569			5,242			5,349
	Total		$	79,145		$	81,713		$	127,342		$	131,379
	Gross margins
	IMAX theater systems
		IMAX systems(2)	$	11,589		$	10,729		$	16,362		$	18,943
		Theater system maintenance		2,781			3,160			5,782			6,214
		Joint revenue sharing arrangements(2)		13,378			13,507			20,661			19,643
				27,748			27,396			42,805			44,800
	Films
		Production and IMAX DMR(2)		18,634			14,936			29,708			24,149
		Distribution(2)		594			309			784			512
		Post-production		364			313			889			-119
				19,592			15,558			31,381			24,542
	Other			454			681			16			483
	Total		$	47,794		$	43,635		$	74,202		$	69,825
	_________
	(1)       The Company's largest customer represents 16.5% and 16.4% for the three and six months ended June 30, 2014, respectively (2013 — 14.3% and 14.3%, respectively).
	(2)       IMAX systems include marketing and commission costs of $0.7 million and $0.9 million for the three and six months ended June 30, 2014, respectively (2013 — $0.4 million and $0.7 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.0 million and $1.2 million for the three and six months ended June 30, 2014, respectively (2013 — $0.9 million and $1.1 million, respectively). Production and DMR segment margins include marketing costs of $2.0 million and $3.2 million for the three and six months ended June 30, 2014, respectively (2013 — $1.4 million and $2.3 million, respectively). Distribution segment margins include marketing costs of $0.2 million and $0.4 million for the three and six months ended June 30, 2014, respectively (2013 — less than $0.1 million and $0.1 million, respectively).
	Geographic Information
	Revenue by geographic area is based on the location of the customer. Revenue related to IMAX DMR is presented based upon the geographic location of the theaters that exhibit the re-mastered films. IMAX DMR revenue is generated through contractual relationships with studios and other third parties and these may not be in the same geographical location as the theater.
		Three Months						Six Months
		Ended June 30,						Ended June 30,
			2014			2013			2014			2013
	Revenue
	United States	$	32,528		$	42,020		$	52,212		$	63,371
	Canada		2,507			3,702			4,632			5,451
	Greater China		17,847			10,931			28,356			21,943
	Asia (excluding Greater China)		8,410			8,158			12,696			12,149
	Western Europe		7,411			5,689			12,407			9,079
	Russia and the CIS		5,105			6,913			7,451			11,852
	Latin America		3,806			3,214			6,062			4,634
	Rest of the World		1,531			1,086			3,526			2,900
	Total	$	79,145		$	81,713		$	127,342		$	131,379
	No single country in the Rest of the World, Western Europe, Latin America and Asia (excluding Greater China) classifications comprise more than 10% of the total revenue.

Employees_Pension_and_Postreti

Employees Pension and Postretirement Benefits	6 Months Ended
	Jun. 30, 2014
Employees Pension and Postretirement Benefits [Abstract]	'
Employees Pension and Postretirement Benefits	'
	16. Employee's Pension and Postretirement Benefits
	(a)  Defined Benefit Plan
	The Company has an unfunded U.S. defined benefit pension plan (the “SERP”) covering Richard L. Gelfond, CEO of the Company and Bradley J. Wechsler, Chairman of the Company's Board of Directors.
	The following table provides disclosure of the pension obligation for the SERP:
							June 30,		December 31,
							2014		2013
	Obligation, beginning of period						$	18,284	$	20,366
	Interest cost							132		195
	Actuarial gain							-		-2,277
	Obligation, end of period and unfunded status						$	18,416	$	18,284
		The following table provides disclosure of pension expense for the SERP:
			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Interest cost		$	66	$	49	$	132	$	98
	Amortization of actuarial loss			-		111		-		222
	Pension expense		$	66	$	160	$	132	$	320
	No contributions are expected to be made for the SERP during 2014. The Company expects interest costs of $0.1 million to be recognized as a component of net periodic benefit cost during the remainder of 2014.
	The accumulated benefit obligation for the SERP was $18.4 million at June 30, 2014 (December 31, 2013 - $18.3 million).
	The following benefit payments are expected to be made as per the current SERP assumptions and the terms of the SERP in each of the next 5 years, and in the aggregate:
	2014 (six months remaining)	$	-
	2015		-
	2016		-
	2017		19,228
	2018		-
	Thereafter		-
		$	19,228
	b)  Defined Contribution Plan
	The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums. During the three and six months ended June 30, 2014, the Company contributed and expensed an aggregate of $0.4 million and $0.7 million, respectively (2013 — $0.4 million and $0.7 million, respectively), to its Canadian plan and an aggregate of $0.1 million and $0.2 million, respectively (2013 —$0.1 million and $0.2 million, respectively), to its defined contribution employee pension plan under Section 401(k) of the U.S. Internal Revenue Code.
	(c)  Postretirement Benefits - Executives
	The Company has an unfunded postretirement plan for Messrs. Gelfond and Wechsler. The plan provides that the Company will maintain health benefits for Messrs. Gelfond and Wechsler until they become eligible for Medicare and, thereafter, the Company will provide Medicare supplement coverage as selected by Messrs. Gelfond and Wechsler. The postretirement benefits obligation as at June 30, 2014 is $0.4 million (December 31, 2013 — $0.4 million). The Company has expensed less than $0.1 million and less than $0.1 million for the three and six months ended June 30, 2014, respectively (2013 — less than $0.1 million and less than $0.1 million, respectively).
	The following benefit payments are expected to be made as per the current plan assumptions in each of the next 5 years:
	2014 (six months remaining)	$	20
	2015		22
	2016		24
	2017		29
	2018		33
	Thereafter		274
		$	402
	(d)  Postretirement Benefits – Canadian Employees
	The Company has an unfunded postretirement plan for its Canadian employees who meet specific eligibility requirements. The Company will provide eligible participants, upon retirement, with health and welfare benefits. The postretirement benefits obligation as at June 30, 2014 is $2.4 million (December 31, 2013 — $2.3 million). The Company has expensed less than $0.1 million and less than $0.1 million for the three and six months ended June 30, 2014, respectively (2013 — less than $0.1 million and less than $0.1 million, respectively).
	In the first quarter of 2013, the Company amended the Canadian postretirement plan to reduce future benefits provided under the plan. As a result of this change, the Company recognized a pre-tax curtailment gain in 2013 of $2.2 million (included in selling, general and administrative expenses) and a reduction in the postretirement liability of $2.6 million.
	The following benefit payments are expected to be made as per the current plan assumptions in each of the next 5 years:
	2014 (six months remaining)	$	76
	2015		89
	2016		99
	2017		110
	2018		116
	Thereafter		1,873
		$	2,363

Financial_Instruments

Financial Instruments	6 Months Ended
	Jun. 30, 2014
Financial Instruments [Abstract]	'
Financial Instruments	'
	17. Financial Instruments
	(a)       Financial Instruments
	The Company maintains cash with various major financial institutions. The Company's cash is invested with highly rated financial institutions.
	The Company's accounts receivables and financing receivables are subject to credit risk. The Company's accounts receivable and financing receivables are concentrated with the theater exhibition industry and film entertainment industry. To minimize the Company's credit risk, the Company retains title to underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. The Company believes it has adequately provided for related exposures surrounding receivables and contractual commitments.
	(b)       Fair Value Measurements
	The carrying values of the Company's cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities due within one year approximate fair values due to the short-term maturity of these instruments. The Company's other financial instruments are comprised of the following:
			As at June 30, 2014						As at December 31, 2013
			Carrying			Estimated			Carrying			Estimated
			Amount			Fair Value			Amount			Fair Value
	Net financed sales receivable	$	92,133		$	91,055		$	93,493		$	92,043
	Net investment in sales-type leases	$	12,736		$	12,414		$	13,617		$	13,214
	Available-for-sale investment	$	700		$	700		$	1,000		$	1,000
	Foreign exchange contracts — designated forwards	$	209		$	209		$	-421		$	-421
	The estimated fair values of the net financed sales receivable and net investment in sales-type leases are estimated based on discounting future cash flows at currently available interest rates with comparable terms (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively.
	The fair value of the Company's available-for-sale investment is determined using the present value of expected cash flows based on projected earnings and other information readily available from the business venture (Level 3 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively. The discounted cash flow valuation technique is based on significant unobservable inputs of revenue and expense projections, appropriately risk weighted, as the investment is in a start-up entity. The significant unobservable inputs used in the fair value measurement of the Company's available-for-sale investment are long-term revenue growth and pretax operating margin. A significant increase (decrease) in any of those inputs in isolation would result in a lower or higher fair value measurement.
	The fair value of foreign currency derivatives is determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively. These identical instruments are traded on a closed exchange.
	There were no significant transfers between Level 1 and Level 2 during the six months ended June 30, 2014 or 2013. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. The table below sets forth a summary of changes in the fair value of the Company's available-for-sale investment measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the period:
				Available For Sale Investments
				2014			2013
	Beginning balance, January 1,			$	1,000		$	1,350
		Transfers into/out of Level 3			-			-
		Total gains or losses (realized/unrealized)
			Included in earnings		-650			-
			Change in other comprehensive income		350			-
		Purchases, issuances, sales and settlements			-			-
	Ending balance, June 30,			$	700		$	1,350
		The amount of total gains or losses for the period included in earnings attributable to the
	change in unrealized gains or losses relating to assets still held at the reporting date			$	-650		$	-
	There were no transfers in or out of the Company's level 3 assets during the six months ended June 30, 2014.
	(c)       Financing Receivables
	The Company's net investment in leases and its net financed sale receivables are subject to the disclosure requirements of ASC 310 “Receivables”. Due to differing risk profiles of its net investment in leases and its net financed sales receivables, the Company views its net investment in leases and its net financed sale receivables as separate classes of financing receivables. The Company does not aggregate financing receivables to assess impairment.
	The Company monitors the credit quality of each customer on a frequent basis through collections and aging analyses. The Company also holds meetings monthly in order to identify credit concerns and whether a change in credit quality classification is required for the customer. A customer may improve in their credit quality classification once a substantial payment is made on overdue balances or the customer has agreed to a payment plan with the Company and payments have commenced in accordance to the payment plan. The change in credit quality indicator is dependent upon management approval.
	The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:
	Good standing — Theater continues to be in good standing with the Company as the client's payments and reporting are up-to-date.
	Credit Watch — Theater operator has begun to demonstrate a delay in payments, has been placed on the Company's credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance, length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "Pre-approved transactions" category, but not in as good of condition as those receivables in "Good standing".
	Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "All transactions suspended" category, but not in as good of condition as those receivables in "Credit Watch." Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired.
	All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended”, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped.
	The following table discloses the recorded investment in financing receivables by credit quality indicator:
		As at June 30, 2014									As at December 31, 2013
		Minimum			Financed						Minimum			Financed
		Lease			Sales						Lease			Sales
		Payments			Receivables			Total			Payments			Receivables			Total
	In good standing	$	11,435		$	90,900		$	102,335		$	12,318		$	89,017		$	101,335
	Credit watch		-			333			333			420			3,895			4,315
	Pre-approved transactions		294			532			826			288			-			288
	Transactions suspended		1,972			861			2,833			1,397			817			2,214
		$	13,701		$	92,626		$	106,327		$	14,423		$	93,729		$	108,152
	While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income.
	The Company's investment in financing receivables on nonaccrual status is as follows:
			As at June 30, 2014						As at December 31, 2013
			Recorded			Related			Recorded			Related
			Investment			Allowance			Investment			Allowance
	Net investment in leases		$	2,265		$	-965		$	1,684		$	-606
	Net financed sales receivables			861			-493			817			-236
			$	3,126		$	-1,458		$	2,501		$	-842
	The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater's aging exceeds 90 days, the Company's policy is to review and assess collectibility on the theater's past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.
	The Company's aged financing receivables are as follows:
			As at June 30, 2014
															Related							Recorded
			Accrued									Billed			Unbilled			Total				Investment
			And									Financing			Recorded			Recorded		Related		Net of
			Current			30-89 Days			90+ Days			Receivables			Investment			Investment		Allowances		Allowances
	Net investment in leases		$	257		$	178		$	1,141		$	1,576		$	12,125		$	13,701	$	-965	$	12,736
Net financed sales receivables			1,911			1,166			4,131			7,208			85,418			92,626		-493		92,133
Total		$	2,168		$	1,344		$	5,272		$	8,784		$	97,543		$	106,327	$	-1,458	$	104,869
		As at December 31, 2013
														Related							Recorded
		Accrued									Billed			Unbilled			Total				Investment
		And									Financing			Recorded			Recorded		Related		Net of
		Current			30-89 Days			90+ Days			Receivables			Investment			Investment		Allowances		Allowances
Net investment in leases		$	444		$	218		$	841		$	1,503		$	12,920		$	14,423	$	-806	$	13,617
Net financed sales receivables			2,502			1,211			3,018			6,731			86,998			93,729		-236		93,493
Total		$	2,946		$	1,429		$	3,859		$	8,234		$	99,918		$	108,152	$	-1,042	$	107,110
The Company's recorded investment in past due financing receivables for which the Company continues to accrue finance income is as follows:
		As at June 30, 2014
														Related					Recorded
		Accrued									Billed			Unbilled					Investment
		And									Financing			Recorded			Related		Past Due
		Current			30-89 Days			90+ Days			Receivables			Investment			Allowance		and Accruing
Net investment in leases		$	108		$	145		$	469		$	722		$	4,796		$	-	$	5,518
Net financed sales receivables			440			387			2,215			3,042			16,586			-		19,628
Total		$	548		$	532		$	2,684		$	3,764		$	21,382		$	-	$	25,146
		As at December 31, 2013
														Related					Recorded
		Accrued									Billed			Unbilled					Investment
		And									Financing			Recorded			Related		Past Due
		Current			30-89 Days			90+ Days			Receivables			Investment			Allowance		and Accruing
Net investment in leases		$	168		$	108		$	205		$	481		$	4,865		$	-200	$	5,146
Net financed sales receivables			450			469			2,056			2,975			19,282			-		22,257
Total		$	618		$	577		$	2,261		$	3,456		$	24,147		$	-200	$	27,403
The Company considers financing receivables to be impaired when it believes it to be probable that it will not recover the full amount of principal and interest owing under the arrangement. The Company uses its knowledge of the industry and economic trends, as well as its prior experiences to determine the amount recoverable for impaired financing receivables. The following table discloses information regarding the Company's impaired financing receivables:
			For the Three Months Ended June 30, 2014
												Average			Interest
			Recorded			Unpaid			Related			Recorded			Income
			Investment			Principal			Allowance			Investment			Recognized
Recorded investment for which there is a related allowance:
		Net financed sales receivables		525			-			-493			524			-
Recorded investment for which there is no related allowance:
		Net financed sales receivables		-			-			-			-			-
Total recorded investment in impaired loans:
		Net financed sales receivables	$	525		$	-		$	-493		$	524		$	-
			For the Three Months Ended June 30, 2013
												Average			Interest
			Recorded			Unpaid			Related			Recorded			Income
			Investment			Principal			Allowance			Investment			Recognized
Recorded investment for which there is a related allowance:
		Net financed sales receivables		188			220			-66			172			-
Recorded investment for which there is no related allowance:
		Net financed sales receivables		358			49			-			363			-
Total recorded investment in impaired loans:
		Net financed sales receivables	$	546		$	269		$	-66		$	535		$	-
			For the Six Months Ended June 30, 2014
												Average			Interest
			Recorded			Unpaid			Related			Recorded			Income
			Investment			Principal			Allowance			Investment			Recognized
Recorded investment for which there is a related allowance:
		Net financed sales receivables		525			-			-493			526			-
Recorded investment for which there is no related allowance:
		Net financed sales receivables		-			-			-			-			-
Total recorded investment in impaired loans:
		Net financed sales receivables	$	525		$	-		$	-493		$	526		$	-
			For the Six Months Ended June 30, 2013
												Average			Interest
			Recorded			Unpaid			Related			Recorded			Income
			Investment			Principal			Allowance			Investment			Recognized
Recorded investment for which there is a related allowance:
		Net financed sales receivables		188			220			-66			172			-
Recorded investment for which there is no related allowance:
		Net financed sales receivables		358			49			-			367			22
Total recorded investment in impaired loans:
		Net financed sales receivables	$	546		$	269		$	-66		$	539		$	22
The Company's activity in the allowance for credit losses for the period and the Company's recorded investment in financing receivables is as follows:
		Three Months Ended June 30, 2014							Six Months Ended June 30, 2014
		Net Investment			Net Financed				Net Investment			Net Financed
		in Leases			Sales Receivables				in Leases			Sales Receivables
Allowance for credit losses:
Beginning balance		$	806		$	488			$	806		$	236
	Provision		159			5				159			257
Ending balance		$	965		$	493			$	965		$	493
Ending balance: individually evaluated for impairment		$	965		$	493			$	965		$	493
Financing receivables:
Ending balance: individually evaluated for impairment		$	13,701		$	92,626			$	13,701		$	92,626
		Three Months Ended June 30, 2013							Six Months Ended June 30, 2013
		Net Investment			Net Financed				Net Investment			Net Financed
		in Leases			Sales Receivables				in Leases			Sales Receivables
Allowance for credit losses:
Beginning balance		$	1,130		$	66			$	1,130		$	66
	Charge-offs		-			-				-			-
	Provision		100			-				100			-
Ending balance		$	1,230		$	66			$	1,230		$	66
Ending balance: individually evaluated for impairment		$	1,230		$	66			$	1,230		$	66
Financing receivables:
Ending balance: individually evaluated for impairment		$	15,690		$	85,692			$	15,690		$	85,692
(d)       Foreign Exchange Risk Management
The Company is exposed to market risk from changes in foreign currency rates. A majority portion of the Company's revenues is denominated in U.S. dollars while a substantial portion of its costs and expenses is denominated in Canadian dollars. A portion of the net U.S. dollar cash flows of the Company is periodically converted to Canadian dollars to fund Canadian dollar expenses through the spot market. In China and Japan the Company has ongoing operating expenses related to its operations in Chinese Renminbi and Japanese yen, respectively. Net cash flows are converted to and from U.S. dollars through the spot market. The Company also has cash receipts under leases denominated in Chinese Renminbi, Japanese yen, Canadian dollar and Euros which are converted to U.S. dollars through the spot market. The Company's policy is to not use any financial instruments for trading or other speculative purposes.
The Company entered into a series of foreign currency forward contracts to manage the Company's risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests at June 30, 2014 (the “Foreign Currency Hedges”), with settlement dates throughout 2015. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the condensed consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the condensed consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations. The Company currently does not hold any derivatives which are not designated as hedging instruments and therefore no gain or loss pertaining to an ineffective portion has been recognized.
The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company's condensed consolidated financial statements:
Notional value foreign exchange contracts as at:
		June 30,			December 31,
			2014			2013
Derivatives designated as hedging instruments:
	Foreign exchange contracts – Forwards	$	23,453		$	23,555
Fair value of derivatives in foreign exchange contracts as at:
			June 30,			December 31,
		Balance Sheet Location	2014			2013
Derivatives designated as hedging instruments:
	Foreign exchange contracts — Forwards	Other assets	$	423		$	-
	Foreign exchange contracts — Forwards	Accrued and other liabilities		-214			-421
			$	209		$	-421
Derivatives in Foreign Currency Hedging relationships are as follows:
			Three Months Ended June 30,						Six Months Ended June 30,
				2014			2013			2014			2013
Foreign exchange contracts - Forwards	Derivative Gain (Loss) Recognized in OCI (Effective Portion)		$	937		$	-498		$	127		$	-800
			$	937		$	-498		$	127		$	-800
	Location of Derivative
	(Loss) Gain Reclassified
	from AOCI into Income		Three Months Ended June 30,						Six Months Ended June 30,
	(Effective Portion)			2014			2013			2014			2013
Foreign exchange contracts - Forwards	Selling, general and administrative expenses		$	-256		$	-82		$	-504		$	48
			$	-256		$	-82		$	-504		$	48
(e)       Investments in New Business Ventures
The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323 or FASB ASC 320, as appropriate. As at June 30, 2014, the equity method of accounting is being utilized for investments with a total carrying value of $1.2 million (December 31, 2013 — $0.4 million). In 2013, the Company contributed $1.4 million, net of its share of costs, to a new business venture in the early-stage of start-up. In the first quarter of 2014, this new business venture was operational. For the three months ended June 30, 2014, gross revenues, cost of revenue and net loss for these investments were $1.4 million, $0.8 million and $0.2 million, respectively (2013 — $0.8 million, $3.2 million and $4.3 million, respectively). For the six months ended June 30, 2014, gross revenues, cost of revenue and net loss for these investments were $2.3 million, $1.7 million and $1.0 million, respectively (2013 — $4.2 million, $6.9 million and $6.5 million, respectively). The difference between the Company's investment balance and the amount of underlying equity in net assets owned by the Company amounts to $0.3 million and relates to goodwill. The Company has determined it is not the primary beneficiary of these VIEs, and therefore these entities have not been consolidated. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under the FASB ASC 320 and is recorded at its fair value of $0.7 million at June 30, 2014 (December 31, 2013 — $1.0 million). In the three and six months ended June 30, 2014, the Company recognized an other-than-temporary impairment of $0.7 million, respectively, for its investment, of which $0.4 million was recognized out of other comprehensive income and $0.3 million as a direct impairment in the condensed consolidated statement of operations. This investment is classified as an available-for-sale investment. The Company has invested $2.5 million in the preferred shares of an enterprise which meet the criteria for classification as an equity security under FASB ASC 325 and accrued $0.5 million pertaining to warrants related to the respective investment (December 31, 2013 – investment of $2.5 million and $0.5 million pertaining to warrants). There has been no change in the value of this investment. The total carrying value of investments in new business ventures at June 30, 2014 is $4.9 million (December 31, 2013 — $5.8 million) and is recorded in Other Assets.

NonControlling_Interests

Non-Controlling Interests	6 Months Ended
	Jun. 30, 2014
Temporary Equity Disclosure [Abstract]	'
Non-Controlling Interests [Text Block]	'
	18. Non-Controlling Interests
	(a)       IMAX China Non-Controlling Interest
	On April 8, 2014, the Company announced the investment in its Greater China business by CMC Capital Partners (“CMC”), an investment fund that is focused on media and entertainment, and FountainVest Partners (“FountainVest”), a China-focused private equity firm. The IMAX China investment provides for the sale and issuance of 20.0% of the shares in IMAX China to entities owned and controlled by CMC and FountainVest, with the intent of further strengthening the Company's competitive position in China.
	Pursuant to the transaction, IMAX China issued the investors 337,500 Common C Shares of par value $0.01 each in the authorized capital of IMAX China (the “Class C Shares”) for an aggregate subscription price of $40.0 million (the “First Closing”) on April 8, 2014 (the “First Completion Date”), and subject to certain conditions, IMAX China agreed to issue to the investors another 337,500 Class C Shares for an aggregate subscription price of $40.0 million (the “Second Closing”) on February 8, 2015 (the “Second Completion Date”). IMAX China remains a consolidated subsidiary of the Company. Beginning in the second quarter of 2014, the Company's condensed consolidated financial statements include the non-controlling interest in the net income of IMAX China resulting from this transaction and the net proceeds are classified as redeemable non-controlling interest in temporary equity.
	Under the shareholders' agreement, except under limited circumstances, holders of Class C Shares may not transfer any Class C Shares prior to the Second Completion Date. After the Second Completion Date, holders of Class C Shares may not transfer any Class C Shares except (i) to certain permitted transferees, (ii) pursuant to any sale of Class C Shares on the public market in connection with or following an IPO, and (iii) subject to the right of first offer of the holder of common A shares of par value $0.01 each in the authorized capital of IMAX China (the “Class A Shares”). With respect to transfers Class A Shares prior to an IPO, the shareholders' agreement also provides certain drag-along rights to the holder of Class A Shares and certain tag-along rights and put rights to holders of Class C Shares.
	The board of directors of IMAX China will initially consist of nine members. The shareholders' agreement provides that each of FountainVest and CMC has the right to nominate one member of IMAX China's board of directors if it owns, (a) at any time prior to the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at the First Completion Date and (b) at any time following the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at both the First Completion Date and Second Completion Date. The holder of Class A Shares has the right to nominate seven members, among which one nominee shall be an independent director reasonably satisfactory to the holders of Class C Shares.
	The shareholders' agreement entered into in connection with the transaction contains restrictions on the transfer of IMAX China's common shares, certain provisions related to the composition of IMAX China's board of directors and certain provisions relating to the redemption and share issuance in lieu of initial public offering of IMAX China's shares and put and call rights relating to change of control of the Company.
	The shareholders' agreement entered into in connection with the transaction provides that IMAX China intends to conduct an IPO of its shares by the fifth anniversary of the First Completion Date. If a qualified IPO (as defined in the shareholders' agreement) has not occurred by such date, each holder of Class C Shares may request that all of such holders' Class C Shares be, at their election, either: (i) redeemed by IMAX China at par value together with the issuance of 2,846,000 of the Company's common shares in the event that the Second Closing is completed, or 1,423,000 of the Company's common shares in the event only the First Closing is completed, (ii) redeemed by IMAX China at par value together with the payment by the Company in cash of the consideration paid by the holders of the Class C Shares, or (iii) exchanged and/or redeemed by IMAX China in a combination of cash and the shares of the Company equal to the pro rata fair market value of IMAX China.
	In the event that the Company reasonably believes that a transaction involving a change of control of the Company will occur, the Company will serve a notice on each holder of Class C Shares. Upon receipt of such notice, each holder of Class C Shares will have the right to cause the Company to purchase all of its Class C Shares, and the holder of Class A Shares will also have the right to purchase from each holder of Class C Shares all of its Class C Shares, each for consideration based upon the pro rata equity value of IMAX China.
	The shareholders' agreement will terminate on the earliest to occur of (i) an IPO, (ii) a redemption or share exchange in lieu of an IPO after the fifth anniversary on the First Completion Date, (iii) completion of a put or call transaction pursuant to a change of control of the Company, and (iv) any date agreed upon in writing by all of the parties to the shareholders' agreement. The shareholders' agreement will also terminate with respect to any shareholder at such time as such shareholder no longer beneficially and legally holds any shares.
	The following summarizes the movement of the non-controlling interest in the Company's subsidiary for the six months ended June 30, 2014:
	Balance as at December 31, 2013			$	-
	Issuance of subsidiary shares to a non-controlling interest				40,000
	Share issuance costs from the issuance of subsidiary shares to a non-controlling interest				-2,843
	Net income				543
	Other comprehensive loss, net of tax				-3
	Accretion charges associated with redeemable common stock				142
	Balance as at June 30, 2014			$	37,839
	(b)       Other Non-Controlling Interest
	In the second quarter of 2014, the Company announced the creation of the IMAX Original Film Fund (the “Film Fund”) to co-finance a portfolio of 10 original large-format films. The Film Fund, which is intended to be capitalized with up to $50.0 million, will finance an ongoing supply of original films that the Company believes will be more exciting and compelling than traditional documentaries. The initial investment in the Film Fund was committed to by a third party in the amount of $25.0 million, with the possibility of contributing additional funds. The Company, which will contribute $9.0 million to the Film Fund over five years, anticipates the Film Fund will be self-perpetuating, with a portion of box office proceeds reinvested into the Film Fund to generate a continuous, steady flow of high-quality documentary content. The related production, financing and distribution agreement includes put and call rights relating to change of control of the rights, title and interest in the co-financed pictures.
	Balance as at December 31, 2013	$	-
	Issuance of subsidiary shares to a non-controlling interest		491
	Share issuance costs from the issuance of subsidiary shares to a non-controlling interest		-713
	Net loss		-71
	Balance as at June 30, 2014	$	-293

Discontinued_Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2014
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	19. Discontinued Operations
	Nyack Theater
	On January 30, 2014, the Company's lease with respect to its owned and operated Nyack IMAX Theater ended and the Company has decided not to renew the respective lease. The transactions of the Company's owned and operated Nyack theater are reflected as a discontinued operation.
	Operating Results for Discontinued Operations
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Services revenue	$	-	$	580	$	35	$	783
	Services cost of sales applicable to revenues (1)		-		-639		537		-993
	Tax (expense) recovery		-		20		-217		71
	Net (loss) income from discontinued operations	$	-	$	-39	$	355	$	-139
	__________
	(1) Upon the expiration of the lease, lease inducements contingent upon the completion of the full term of the lease were recognized as a reduction in rent expense of $0.8 million (2013 - $nil).

Prior_Periods_Figures

Prior Periods' Figures	6 Months Ended
	Jun. 30, 2014
Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]	'
Prior Periods' Figures	'
	20. Prior Periods' Figures
	Certain of the prior periods' figures have been reclassified to conform to the current period's presentation.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2014
Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]	'
Basis of Accounting	'
	IMAX Corporation, together with its wholly-owned subsidiaries (the “Company”), prepares its financial statements in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”).
	The condensed consolidated financial statements include the accounts of the Company together with its wholly-owned subsidiaries, except for subsidiaries which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. The nature of the Company's business is such that the results of operations for the interim periods presented are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all normal and recurring adjustments necessary to make the results of operations for the interim periods a fair statement of such operations.
	All significant intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.
Variable interest entities	'
	The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”). The Company has 11 film production companies that are VIEs. For 4 of the Company's film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE's economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. The Company continues to consolidate these entities, with no material impact on the operating results or financial condition of the Company, as these production companies have total assets of $0.2 million and total liabilities of $0.1 million as at June 30, 2014 (December 31, 2013 — assets and liabilities of $nil, respectively). For the other 7 film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at June 30, 2014, these 7 VIEs have total assets of $0.5 million (December 31, 2013 — $5.2 million) and total liabilities of $0.5 million (December 31, 2013 — $5.2 million). Earnings of the investees included in the Company's condensed consolidated statement of operations amounted to $nil and $nil for the three and six months ended June 30, 2014, respectively (2013 — $nil and $nil, respectively). The carrying value of these investments in VIEs that are not consolidated is $nil at June 30, 2014 (December 31, 2013 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the condensed consolidated statement of operations. The Company's exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $0.6 million at June 30, 2014 (December 31, 2013 — $1.5 million).
Equity and Cost Method Investments Policy	'
	The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) or ASC 320 − “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate.
New Accounting Pronouncements	'
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contract with Customers (Topic 606)” (“ASU 2014-09”). The purpose of the amendment is to clarify the principles for recognizing revenue and developing common revenue standards between US GAAP and IFRS, through the application of a single comprehensive model for Company's to use in accounting for revenue arising from contracts with customers. Under this amended standard, the Company will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. For public entities, the amendments are effective for interim and annual reporting periods beginning after December 15, 2016. The Company is currently assessing the impact of ASU 2014-09 on its consolidated financial statements.
Guarantees Indemnifications And Warranties Policies	'
	In accordance with the Contingencies Topic of the FASB ASC, the Company will make a provision for a liability when it is both probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has adequate provisions for any such matters. The Company reviews these provisions in conjunction with any related provisions on assets related to the claims at least quarterly and adjusts these provisions to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other pertinent information related to the case.
	The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.
Income tax policy	'
	The Company's effective tax rate differs from the statutory tax rate and varies from year to year primarily as a result of permanent differences, investment and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted statutory tax rate increases or reductions in the year, changes due to foreign exchange, changes in the Company's valuation allowance based on the Company's recoverability assessments of deferred tax assets, and favorable or unfavorable resolution of various tax examinations.
Segment Reporting Policy	'
	The accounting policies of the segments are the same as those described in note 2 to the audited consolidated financial statements included in the Company's 2013 Form 10-K.
Fair Value of Financial Instruments Policy	'
	The estimated fair values of the net financed sales receivable and net investment in sales-type leases are estimated based on discounting future cash flows at currently available interest rates with comparable terms (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively.
	The fair value of the Company's available-for-sale investment is determined using the present value of expected cash flows based on projected earnings and other information readily available from the business venture (Level 3 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively. The discounted cash flow valuation technique is based on significant unobservable inputs of revenue and expense projections, appropriately risk weighted, as the investment is in a start-up entity. The significant unobservable inputs used in the fair value measurement of the Company's available-for-sale investment are long-term revenue growth and pretax operating margin. A significant increase (decrease) in any of those inputs in isolation would result in a lower or higher fair value measurement.
	The fair value of foreign currency derivatives is determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at June 30, 2014 and December 31, 2013, respectively. These identical instruments are traded on a closed exchange.
Fair Value Transfer Policy	'
	There were no significant transfers between Level 1 and Level 2 during the six months ended June 30, 2014 or 2013. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement.
Credit Risk Policy	'
	The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:
	Good standing — Theater continues to be in good standing with the Company as the client's payments and reporting are up-to-date.
	Credit Watch — Theater operator has begun to demonstrate a delay in payments, has been placed on the Company's credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance, length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "Pre-approved transactions" category, but not in as good of condition as those receivables in "Good standing".
	Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "All transactions suspended" category, but not in as good of condition as those receivables in "Credit Watch." Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired.
	All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended”, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped.
Condition for Company's policy to review and assess collectability on theater's past due accounts	'
	While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income.
	The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater's aging exceeds 90 days, the Company's policy is to review and assess collectibility on the theater's past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.
	The Company considers financing receivables to be impaired when it believes it to be probable that it will not recover the full amount of principal and interest owing under the arrangement.
Derivatives policy	'
	The Company entered into a series of foreign currency forward contracts to manage the Company's risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests at June 30, 2014 (the “Foreign Currency Hedges”), with settlement dates throughout 2015. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the condensed consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the condensed consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations. The Company currently does not hold any derivatives which are not designated as hedging instruments and therefore no gain or loss pertaining to an ineffective portion has been recognized.
Comparability Of Prior Year Financial Data	'
	Certain of the prior periods' figures have been reclassified to conform to the current period's presentation

Financing_Receivables_Tables

Financing Receivables (Tables)	6 Months Ended
	Jun. 30, 2014
Financing Receivables [Abstract]	'
Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales	'
		June 30,		December 31,
		2014		2013
	Gross minimum lease payments receivable	$	16,447	$	17,475
	Unearned finance income		-2,746		-3,052
	Minimum lease payments receivable		13,701		14,423
	Accumulated allowance for uncollectible amounts		-965		-806
	Net investment in leases		12,736		13,617
	Gross financed sales receivables		126,994		129,398
	Unearned finance income		-34,368		-35,669
	Financed sales receivables		92,626		93,729
	Accumulated allowance for uncollectible amounts		-493		-236
	Net financed sales receivables		92,133		93,493
	Total financing receivables	$	104,869	$	107,110
	Net financed sales receivables due within one year	$	16,598	$	17,335
	Net financed sales receivables due after one year	$	75,535	$	76,158

Inventories_Tables

Inventories (Tables)	6 Months Ended
	Jun. 30, 2014
Inventories [Abstract]	'
Inventories	'
		June 30,		December 31,
		2014		2013
	Raw materials	$	7,983	$	4,321
	Work-in-process		953		500
	Finished goods		7,828		5,004
		$	16,764	$	9,825

Property_Plant_and_Equipment_T

Property Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
			As at June 30, 2014
					Accumulated		Net Book
			Cost		Depreciation		Value
	Equipment leased or held for use
		Theater system components	$	166,796	$	57,542	$	109,254
		Camera equipment		5,442		2,921		2,521
				172,238		60,463		111,775
	Assets under construction			17,267		-		17,267
	Other property, plant and equipment
		Land		8,114		-		8,114
		Buildings		15,948		10,696		5,252
		Office and production equipment		28,237		20,363		7,874
		Leasehold improvements		9,924		9,387		537
				62,223		40,446		21,777
			$	251,728	$	100,909	$	150,819
			As at December 31, 2013
					Accumulated		Net Book
			Cost		Depreciation		Value
	Equipment leased or held for use
		Theater system components	$	158,192	$	51,537	$	106,655
		Camera equipment		4,591		2,736		1,855
				162,783		54,273		108,510
	Assets under construction			8,055		-		8,055
	Other property, plant and equipment
		Land		1,593		-		1,593
		Buildings		15,832		10,410		5,422
		Office and production equipment		27,190		18,707		8,483
		Leasehold improvements		9,884		9,100		784
				54,499		38,217		16,282
			$	225,337	$	92,490	$	132,847

Other_Intangible_Assets_Tables

Other Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2014
Other Intangible Assets [Abstract]	'
Other Intangible Assets	'
		As at June 30, 2014
				Accumulated		Net Book
		Cost		Amortization		Value
	Patents and trademarks	$	9,387	$	6,001	$	3,386
	Licenses and intellectual property		19,990		4,051		15,939
	Other		8,892		1,238		7,654
		$	38,269	$	11,290	$	26,979
		As at December 31, 2013
				Accumulated		Net Book
		Cost		Amortization		Value
	Patents and trademarks	$	8,774	$	5,741	$	3,033
	Licenses and intellectual property		19,950		3,260		16,690
	Other		8,843		821		8,022
		$	37,567	$	9,822	$	27,745
	2014 (six months remaining)	$	1,468
	2015		2,833
	2016		2,654
	2017		2,654
	2018		2,654

Contingencies_and_Guarantees_T

Contingencies and Guarantees (Tables)	6 Months Ended
	Jun. 30, 2014
Commitments, Contingencies and Guarantees [Abstract]	'
Accrual for product warranties	'
		June 30,		December 31,
		2014		2013
	Balance at the beginning of period	$	7	$	32
	Warranty redemptions		-5		-77
	Warranties issued		5		52
	Balance at the end of period	$	7	$	7

Condensed_Consolidated_Stateme6

Condensed Consolidated Statements of Cash Flows Supplemental Information (Tables)	6 Months Ended
	Jun. 30, 2014
Condensed Consolidated Statements of Cash Flows Supplemental Information [Abstract]	'
Changes in other non-cash operating assets and liabilities	'
			Six Months
			Ended June 30,
			2014		2013
	(Increase) decrease in:
		Accounts receivable	$	-398	$	-20,661
		Financing receivables		2,074		-5,994
		Inventories		-7,012		-1,717
		Prepaid expenses		-842		-739
		Commissions and other deferred selling expenses		-686		-131
		Insurance recoveries		10,958		112
		Other assets		-602		-74
	Increase (decrease) in:
		Accounts payable		-6,908		4,132
		Accrued and other liabilities(1)		-11,005		109
		Deferred revenue		11,202		-38
			$	-3,219	$	-25,001
Cash payments	'
		(b) Cash payments made on account of:
			Six Months
			Ended June 30,
			2014		2013
	Income taxes		$	3,729	$	301
	Interest		$	-	$	347
Summary of depreciation and amortization	'
		(c) Depreciation and amortization are comprised of the following:
			Six Months
			Ended June 30,
				2014		2013
	Film assets		$	5,343	$	10,020
	Property, plant and equipment
		Joint revenue sharing arrangements		5,852		5,819
		Other property, plant and equipment		2,676		2,454
	Other intangible assets			1,468		1,397
	Other assets			343		286
	Deferred financing costs			263		225
			$	15,945	$	20,201
Write downs, net of recoveries	'
		(d) Write-downs, net of recoveries, are comprised of the following:
			Six Months
			Ended June 30,
				2014		2013
	Impairment of available-for-sale investment		$	650	$	-
	Accounts receivable			449		-45
	Financing receivables			167		100
	Property, plant and equipment			270		-
	Inventories			43		-
			$	1,579	$	55

Receivable_Provisions_Net_of_R1

Receivable Provisions Net of Recoveries (Tables)	6 Months Ended
	Jun. 30, 2014
Receivable Provisions, Net of Recoveries [Abstract]	'
Receivable Provisions, Net of Recoveries	'
		Three Months				Six Months
		Ended June 30,				Ended June 30,
		2014		2013		2014		2013
	Accounts receivable provisions, net of recoveries	$	329	$	-45	$	449	$	-45
	Financing receivables, net of recoveries		-		100		167		100
	Receivable provisions, net of recoveries	$	329	$	55	$	616	$	55

Income_Taxes_Tables

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2014
Income Taxes [Abstract]	'
Income Tax Effect on Comprehensive Income	'
		Three Months				Six Months
		Ended June 30,				Ended June 30,
		2014		2013		2014		2013
	Unrealized change in cash flow hedging instruments	$	-242	$	129	$	-159	$	206
	Realized change in cash flow hedging instruments upon settlement		-66		-22		-1		11
	Other-than-temporary impairment of available-for-sale investment		-45		-		-45		-
	Foreign currency translation adjustments		7		-61		40		26
	Amortization of actuarial loss on defined benefit plan		-		-29		-		-58
	Gain on curtailment of postretirement benefit plan		-		-		-		-100
		$	-346	$	17	$	-165	$	85

Capital_Stock_Tables

Capital Stock (Tables)	6 Months Ended
	Jun. 30, 2014
Capital Stock [Abstract]	'
Weighted average fair value of common share granted to employees	'
			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Average risk-free interest rate		n/a		1.10%		2.50%		1.34%
	Expected option life (in years)		n/a		4.63		4.48 - 5.82		4.62 - 4.63
	Expected volatility		n/a		40%		37.50%		40%
	Annual termination probability		n/a		8.46% - 8.52%		0% - 8.40%		8.46% - 8.52%
	Dividend yield		n/a		0%		0%		0%
Options to Non-Employees	'
			Three Months				Six Months
			Ended June 30,				Ended June 30,
			2014		2013		2014		2013
	Average risk-free interest rate		n/a		1.64%		n/a		1.64%
	Contractual option life		n/a		7 Years		n/a		7 Years
	Average expected volatility		n/a		40%		n/a		40%
	Dividend yield		n/a		0%		n/a		0%
Option activity under the Stock Option Plan	'
								Weighted Average Exercise
			Number of Shares					Price Per Share
			2014		2013		2014			2013
	Options outstanding, beginning of period		6,263,121		7,441,068		$	21.11		$	18.48
	Granted		828,353		192,112			27.44			25.46
	Exercised		-505,187		-579,681			5.26			6.89
	Forfeited		-10,000		-69,658			18.98			26.58
	Cancelled		-23,787		-1,550			33.6			28.78
	Options outstanding, end of period		6,552,500		6,982,291			23.09			19.56
	Options exercisable, end of period		3,656,730		3,477,935			21.35			17.17
Movement of Restricted Stock Units	'
			Number of Awards				Weighted Average Grant Date Fair Value Per Share
			2014		2013		2014			2013
	RSUs outstanding, beginning of period		264,140		-		$	26.14		$	-
	Granted		482,588		277,198			27.41			26.28
	Vested and settled		-104,612		-39,761			26.13			26.28
	RSUs outstanding, end of period		642,116		237,437			27.09			26.28
Basic and diluted per-share computations	'
			Three Months							Six Months
			Ended June 30,							Ended June 30,
			2014			2013			2014			2013
	Net income attributable to Common Shareholders		$	13,307		$	11,816		$	13,886		$	14,677
	Less: Accretion charges associated with redeemable common stock			-142			-			-142			-
	Net income applicable to Common Shareholders		$	13,165		$	11,816		$	13,744		$	14,677
	Weighted average number of common shares (000's):
	Issued and outstanding, beginning of period			67,957			66,866			67,841			66,482
	Weighted average number of shares issued during the period			271			86			227			317
	Weighted average number of shares used in computing basic income per share			68,228			66,952			68,068			66,799
	Assumed exercise of stock options and RSUs, net of shares assumed repurchased			1,224			1,941			1,380			1,970
	Weighted average number of shares used in computing diluted income per share			69,452			68,893			69,448			68,769
Movement of Shareholders' Equity	'
	Balance as at December 31, 2013			$	319,585
	Net income attributable to Common Shareholders				13,886
	Adjustments to capital stock:
		Cash received from issuance of common shares			2,657
		Issuance of common shares for vested RSUs			2,000
		Fair value of stock options exercised at date of grant			641
	Adjustments to other equity:
		Employee stock options granted			4,540
		Non-employee stock options granted			149
		Fair value of stock options exercised at date of grant			-641
		RSUs granted			3,335
		RSUs vested			-2,792
		Excess tax benefits from RSUs			13
	Adjustment for accretion charges associated with redeemable common stock				-142
	Adjustments to accumulated other comprehensive loss:
		Unrealized net gain from cash flow hedging instruments			127
		Realization of cash flow hedging net loss upon settlement			504
		Other-than-temporary impairment of available-for-sale investment			350
		Foreign currency translation adjustments			-175
		Tax effect of movement in other comprehensive income			-165
	Balance as at June 30, 2014			$	343,872

Segment_Information_Tables

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2014
Segmented Information [Abstract]	'
Inter-segment revenue	'
			Three Months						Six Months
			Ended June 30,						Ended June 30,
				2014			2013		2014			2013
	Revenue(1)
	IMAX theater systems
		IMAX systems	$	17,996		$	20,792		$	25,756		$	33,530
		Theater system maintenance		8,673			7,952			16,868			15,741
		Joint revenue sharing arrangements		19,363			18,336			30,219			27,712
				46,032			47,080			72,843			76,983
	Films
		Production and IMAX DMR		24,050			25,952			39,235			40,307
		Distribution		2,942			2,185			4,405			4,672
		Post-production		2,391			2,927			5,617			4,068
				29,383			31,064			49,257			49,047
	Other			3,730			3,569			5,242			5,349
	Total		$	79,145		$	81,713		$	127,342		$	131,379
	Gross margins
	IMAX theater systems
		IMAX systems(2)	$	11,589		$	10,729		$	16,362		$	18,943
		Theater system maintenance		2,781			3,160			5,782			6,214
		Joint revenue sharing arrangements(2)		13,378			13,507			20,661			19,643
				27,748			27,396			42,805			44,800
	Films
		Production and IMAX DMR(2)		18,634			14,936			29,708			24,149
		Distribution(2)		594			309			784			512
		Post-production		364			313			889			-119
				19,592			15,558			31,381			24,542
	Other			454			681			16			483
	Total		$	47,794		$	43,635		$	74,202		$	69,825
		Three Months						Six Months
		Ended June 30,						Ended June 30,
			2014			2013			2014			2013
	Revenue
	United States	$	32,528		$	42,020		$	52,212		$	63,371
	Canada		2,507			3,702			4,632			5,451
	Greater China		17,847			10,931			28,356			21,943
	Asia (excluding Greater China)		8,410			8,158			12,696			12,149
	Western Europe		7,411			5,689			12,407			9,079
	Russia and the CIS		5,105			6,913			7,451			11,852
	Latin America		3,806			3,214			6,062			4,634
	Rest of the World		1,531			1,086			3,526			2,900
	Total	$	79,145		$	81,713		$	127,342		$	131,379

Employees_Pension_and_Postreti1

Employees Pension and Postretirement Benefits (Tables)	6 Months Ended
	Jun. 30, 2014
SERP Benefits [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Amounts accrued	'
							June 30,		December 31,
							2014		2013
	Obligation, beginning of period						$	18,284	$	20,366
	Interest cost							132		195
	Actuarial gain							-		-2,277
	Obligation, end of period and unfunded status						$	18,416	$	18,284
Pension Expense	'
		The following table provides disclosure of pension expense for the SERP:
			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Interest cost		$	66	$	49	$	132	$	98
	Amortization of actuarial loss			-		111		-		222
	Pension expense		$	66	$	160	$	132	$	320
Schedule of expected benefit payments	'
	2014 (six months remaining)	$	-
	2015		-
	2016		-
	2017		19,228
	2018		-
	Thereafter		-
		$	19,228
Postretirement Benefits Executive [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Schedule of expected benefit payments	'
	2014 (six months remaining)	$	20
	2015		22
	2016		24
	2017		29
	2018		33
	Thereafter		274
		$	402
Postretirement Benefits Canadian Employees [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Schedule of expected benefit payments	'
	2014 (six months remaining)	$	76
	2015		89
	2016		99
	2017		110
	2018		116
	Thereafter		1,873
		$	2,363

Financial_Instruments_Tables

Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2014
Financial Instruments [Abstract]	'
Fair Value of Financial Instruments	'
			As at June 30, 2014						As at December 31, 2013
			Carrying			Estimated			Carrying			Estimated
			Amount			Fair Value			Amount			Fair Value
	Net financed sales receivable	$	92,133		$	91,055		$	93,493		$	92,043
	Net investment in sales-type leases	$	12,736		$	12,414		$	13,617		$	13,214
	Available-for-sale investment	$	700		$	700		$	1,000		$	1,000
	Foreign exchange contracts — designated forwards	$	209		$	209		$	-421		$	-421
Summary of changes in the fair value	'
				Available For Sale Investments
				2014			2013
	Beginning balance, January 1,			$	1,000		$	1,350
		Transfers into/out of Level 3			-			-
		Total gains or losses (realized/unrealized)
			Included in earnings		-650			-
			Change in other comprehensive income		350			-
		Purchases, issuances, sales and settlements			-			-
	Ending balance, June 30,			$	700		$	1,350
		The amount of total gains or losses for the period included in earnings attributable to the
	change in unrealized gains or losses relating to assets still held at the reporting date			$	-650		$	-
Recorded Investment in Financing Receivables	'
		As at June 30, 2014									As at December 31, 2013
		Minimum			Financed						Minimum			Financed
		Lease			Sales						Lease			Sales
		Payments			Receivables			Total			Payments			Receivables			Total
	In good standing	$	11,435		$	90,900		$	102,335		$	12,318		$	89,017		$	101,335
	Credit watch		-			333			333			420			3,895			4,315
	Pre-approved transactions		294			532			826			288			-			288
	Transactions suspended		1,972			861			2,833			1,397			817			2,214
		$	13,701		$	92,626		$	106,327		$	14,423		$	93,729		$	108,152
Investment In Financing Receivables On Nonaccrual Status	'
			As at June 30, 2014						As at December 31, 2013
			Recorded			Related			Recorded			Related
			Investment			Allowance			Investment			Allowance
	Net investment in leases		$	2,265		$	-965		$	1,684		$	-606
	Net financed sales receivables			861			-493			817			-236
			$	3,126		$	-1,458		$	2,501		$	-842
Aging of Financing Receivables	'
			As at June 30, 2014
															Related							Recorded
			Accrued									Billed			Unbilled			Total				Investment
			And									Financing			Recorded			Recorded		Related		Net of
			Current			30-89 Days			90+ Days			Receivables			Investment			Investment		Allowances		Allowances
	Net investment in leases		$	257		$	178		$	1,141		$	1,576		$	12,125		$	13,701	$	-965	$	12,736
	Net financed sales receivables			1,911			1,166			4,131			7,208			85,418			92,626		-493		92,133
	Total		$	2,168		$	1,344		$	5,272		$	8,784		$	97,543		$	106,327	$	-1,458	$	104,869
			As at December 31, 2013
															Related							Recorded
			Accrued									Billed			Unbilled			Total				Investment
			And									Financing			Recorded			Recorded		Related		Net of
			Current			30-89 Days			90+ Days			Receivables			Investment			Investment		Allowances		Allowances
	Net investment in leases		$	444		$	218		$	841		$	1,503		$	12,920		$	14,423	$	-806	$	13,617
	Net financed sales receivables			2,502			1,211			3,018			6,731			86,998			93,729		-236		93,493
	Total		$	2,946		$	1,429		$	3,859		$	8,234		$	99,918		$	108,152	$	-1,042	$	107,110
Financing receivables continues to accrue finance income	'
			As at June 30, 2014
															Related					Recorded
			Accrued									Billed			Unbilled					Investment
			And									Financing			Recorded			Related		Past Due
			Current			30-89 Days			90+ Days			Receivables			Investment			Allowance		and Accruing
	Net investment in leases		$	108		$	145		$	469		$	722		$	4,796		$	-	$	5,518
	Net financed sales receivables			440			387			2,215			3,042			16,586			-		19,628
	Total		$	548		$	532		$	2,684		$	3,764		$	21,382		$	-	$	25,146
			As at December 31, 2013
															Related					Recorded
			Accrued									Billed			Unbilled					Investment
			And									Financing			Recorded			Related		Past Due
			Current			30-89 Days			90+ Days			Receivables			Investment			Allowance		and Accruing
	Net investment in leases		$	168		$	108		$	205		$	481		$	4,865		$	-200	$	5,146
	Net financed sales receivables			450			469			2,056			2,975			19,282			-		22,257
	Total		$	618		$	577		$	2,261		$	3,456		$	24,147		$	-200	$	27,403
Impaired financing receivables	'
				For the Three Months Ended June 30, 2014
													Average			Interest
				Recorded			Unpaid			Related			Recorded			Income
				Investment			Principal			Allowance			Investment			Recognized
	Recorded investment for which there is a related allowance:
			Net financed sales receivables		525			-			-493			524			-
	Recorded investment for which there is no related allowance:
			Net financed sales receivables		-			-			-			-			-
	Total recorded investment in impaired loans:
			Net financed sales receivables	$	525		$	-		$	-493		$	524		$	-
				For the Three Months Ended June 30, 2013
													Average			Interest
				Recorded			Unpaid			Related			Recorded			Income
				Investment			Principal			Allowance			Investment			Recognized
	Recorded investment for which there is a related allowance:
			Net financed sales receivables		188			220			-66			172			-
	Recorded investment for which there is no related allowance:
			Net financed sales receivables		358			49			-			363			-
	Total recorded investment in impaired loans:
			Net financed sales receivables	$	546		$	269		$	-66		$	535		$	-
				For the Six Months Ended June 30, 2014
													Average			Interest
				Recorded			Unpaid			Related			Recorded			Income
				Investment			Principal			Allowance			Investment			Recognized
	Recorded investment for which there is a related allowance:
			Net financed sales receivables		525			-			-493			526			-
	Recorded investment for which there is no related allowance:
			Net financed sales receivables		-			-			-			-			-
	Total recorded investment in impaired loans:
			Net financed sales receivables	$	525		$	-		$	-493		$	526		$	-
				For the Six Months Ended June 30, 2013
													Average			Interest
				Recorded			Unpaid			Related			Recorded			Income
				Investment			Principal			Allowance			Investment			Recognized
	Recorded investment for which there is a related allowance:
			Net financed sales receivables		188			220			-66			172			-
	Recorded investment for which there is no related allowance:
			Net financed sales receivables		358			49			-			367			22
	Total recorded investment in impaired loans:
			Net financed sales receivables	$	546		$	269		$	-66		$	539		$	22
Allowance for credit losses and investment in financing receivables	'
			Three Months Ended June 30, 2014							Six Months Ended June 30, 2014
			Net Investment			Net Financed				Net Investment			Net Financed
			in Leases			Sales Receivables				in Leases			Sales Receivables
	Allowance for credit losses:
	Beginning balance		$	806		$	488			$	806		$	236
		Provision		159			5				159			257
	Ending balance		$	965		$	493			$	965		$	493
	Ending balance: individually evaluated for impairment		$	965		$	493			$	965		$	493
	Financing receivables:
	Ending balance: individually evaluated for impairment		$	13,701		$	92,626			$	13,701		$	92,626
			Three Months Ended June 30, 2013							Six Months Ended June 30, 2013
			Net Investment			Net Financed				Net Investment			Net Financed
			in Leases			Sales Receivables				in Leases			Sales Receivables
	Allowance for credit losses:
	Beginning balance		$	1,130		$	66			$	1,130		$	66
		Charge-offs		-			-				-			-
		Provision		100			-				100			-
	Ending balance		$	1,230		$	66			$	1,230		$	66
	Ending balance: individually evaluated for impairment		$	1,230		$	66			$	1,230		$	66
	Financing receivables:
	Ending balance: individually evaluated for impairment		$	15,690		$	85,692			$	15,690		$	85,692
Notional amount of derivative	'
			June 30,			December 31,
				2014			2013
	Derivatives designated as hedging instruments:
		Foreign exchange contracts – Forwards	$	23,453		$	23,555
Fair value of foreign exchange contracts	'
				June 30,			December 31,
			Balance Sheet Location	2014			2013
	Derivatives designated as hedging instruments:
		Foreign exchange contracts — Forwards	Other assets	$	423		$	-
		Foreign exchange contracts — Forwards	Accrued and other liabilities		-214			-421
				$	209		$	-421
Derivatives in Foreign Currency Hedging relationships	'
				Three Months Ended June 30,						Six Months Ended June 30,
					2014			2013			2014			2013
	Foreign exchange contracts - Forwards	Derivative Gain (Loss) Recognized in OCI (Effective Portion)		$	937		$	-498		$	127		$	-800
				$	937		$	-498		$	127		$	-800
		Location of Derivative
		(Loss) Gain Reclassified
		from AOCI into Income		Three Months Ended June 30,						Six Months Ended June 30,
		(Effective Portion)			2014			2013			2014			2013
	Foreign exchange contracts - Forwards	Selling, general and administrative expenses		$	-256		$	-82		$	-504		$	48
				$	-256		$	-82		$	-504		$	48

NonControlling_Interests_Table

Non-Controlling Interests (Tables)	6 Months Ended
	Jun. 30, 2014
IMAX China Noncontrolling Interest	'
Non-controlling Interests	'
Non-controlling Interests	'
	Balance as at December 31, 2013			$	-
	Issuance of subsidiary shares to a non-controlling interest				40,000
	Share issuance costs from the issuance of subsidiary shares to a non-controlling interest				-2,843
	Net income				543
	Other comprehensive loss, net of tax				-3
	Accretion charges associated with redeemable common stock				142
	Balance as at June 30, 2014			$	37,839
Other Noncontrolling Interest [Member]	'
Non-controlling Interests	'
Non-controlling Interests	'
	Balance as at December 31, 2013	$	-
	Issuance of subsidiary shares to a non-controlling interest		491
	Share issuance costs from the issuance of subsidiary shares to a non-controlling interest		-713
	Net loss		-71
	Balance as at June 30, 2014	$	-293

Discontinued_Operations_Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2014
Discontinued Operations And Disposal Groups [Abstract]	'
Schedule of Discontinued Operations	'
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Services revenue	$	-	$	580	$	35	$	783
	Services cost of sales applicable to revenues (1)		-		-639		537		-993
	Tax (expense) recovery		-		20		-217		71
	Net (loss) income from discontinued operations	$	-	$	-39	$	355	$	-139

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Basis of Presentation (Textuals) [Abstract]	'	'	'	'	'
Number Of Variable Interest Entities	'	'	'11	'	'
Number Of Variable Interest Entities Primary Beneficiary	'	'	'4	'	'
Number Of Variable Interest Entities Not A Primary Beneficiary	'	'	'7	'	'
Variable interest entity, non-consolidated, Assets	$0.50	'	$0.50	'	'
Variable interest entity, non-consolidated, Liabilities	0.5	'	0.5	'	'
Total carrying value of investments in new business ventures	4.9	'	4.9	'	5.8
Investment in preferred stock of other business venture - fair value	0.7	'	0.7	'	1
Investment in preferred stock of other business venture - cost	1.5	'	1.5	'	'
Cost Method Investments Original Cost	2.5	'	2.5	'	2.5
Warrants	0.5	'	0.5	'	0.5
Variable Interest Entity, Primary Beneficiary [Member]	'	'	'	'	'
Basis of Presentation (Textuals) [Abstract]	'	'	'	'	'
Variable interest entity, consolidated, Assets	0.2	'	0.2	'	0
Variable interest entity, consolidated, Liabilities	0.1	'	0.1	'	0
Variable Interest Entity, Not Primary Beneficiary [Member]	'	'	'	'	'
Basis of Presentation (Textuals) [Abstract]	'	'	'	'	'
Variable interest entity, non-consolidated, Assets	0.5	'	0.5	'	5.2
Variable interest entity, non-consolidated, Liabilities	0.5	'	0.5	'	5.2
Earnings of the investees	0	0	0	0	'
Loss exposure	0.6	'	0.6	'	1.5
Carrying value of equity investments	1.2	'	1.2	'	0.4
Carrying value of film production company VIEs	0	'	0	'	0
Variable Interest Entity, Not Primary Beneficiary [Member] | New Equity Accounted Investment [Member]	'	'	'	'	'
Basis of Presentation (Textuals) [Abstract]	'	'	'	'	'
Carrying value of equity investments	'	'	'	'	$1.40

Financing_Receivables_Details

Financing Receivables (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales	'	'
Gross minimum lease payments receivable	$16,447	$17,475
Unearned finance income	-2,746	-3,052
Minimum lease payments receivable	13,701	14,423
Accumulated allowance for uncollectible amounts	-965	-806
Net investment in leases	12,736	13,617
Gross financed sales receivables	126,994	129,398
Unearned finance income	-34,368	-35,669
Financed sales receivables	92,626	93,729
Accumulated allowance for uncollectible amounts	-493	-236
Net financed sales receivables	92,133	93,493
Total financing receivables	104,869	107,110
Net financed sales receivables due within one year	16,598	17,335
Net financed sales receivables due after one year	$75,535	$76,158

Inventories_Details

Inventories (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventories	'	'
Raw materials	$7,983	$4,321
Work-in-process	953	500
Finished goods	7,828	5,004
Total	$16,764	$9,825

Property_Plant_and_Equipment_D

Property Plant and Equipment (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, plant and equipment	'	'
Cost	$251,728	$225,337
Accumulated Depreciation	100,909	92,490
Net Book Value	150,819	132,847
Equipment leased or held for use [Member]	'	'
Property, plant and equipment	'	'
Cost	172,238	162,783
Accumulated Depreciation	60,463	54,273
Net Book Value	111,775	108,510
Theater System Components [Member]	'	'
Property, plant and equipment	'	'
Cost	166,796	158,192
Accumulated Depreciation	57,542	51,537
Net Book Value	109,254	106,655
Camera Equipment [Member]	'	'
Property, plant and equipment	'	'
Cost	5,442	4,591
Accumulated Depreciation	2,921	2,736
Net Book Value	2,521	1,855
Assets Under Construction [Member]	'	'
Property, plant and equipment	'	'
Cost	17,267	8,055
Accumulated Depreciation	0	0
Net Book Value	17,267	8,055
Other property, plant and equipment [Member]	'	'
Property, plant and equipment	'	'
Cost	62,223	54,499
Accumulated Depreciation	40,446	38,217
Net Book Value	21,777	16,282
Land [Member]	'	'
Property, plant and equipment	'	'
Cost	8,114	1,593
Accumulated Depreciation	0	0
Net Book Value	8,114	1,593
Buildings [Member]	'	'
Property, plant and equipment	'	'
Cost	15,948	15,832
Accumulated Depreciation	10,696	10,410
Net Book Value	5,252	5,422
Office and Production Equipment [Member]	'	'
Property, plant and equipment	'	'
Cost	28,237	27,190
Accumulated Depreciation	20,363	18,707
Net Book Value	7,874	8,483
Leasehold Improvements [Member]	'	'
Property, plant and equipment	'	'
Cost	9,924	9,884
Accumulated Depreciation	9,387	9,100
Net Book Value	$537	$784

Other_Intangible_Assets_Detail

Other Intangible Assets (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other Intangible Assets	'	'
Other Intangible Assets, Cost	$38,269	$37,567
Other Intangible Assets, Accumulated Amortization	11,290	9,822
Other Intangible Assets, Net Book Value	26,979	27,745
Patents and Trademarks [Member]	'	'
Other Intangible Assets	'	'
Other Intangible Assets, Cost	9,387	8,774
Other Intangible Assets, Accumulated Amortization	6,001	5,741
Other Intangible Assets, Net Book Value	3,386	3,033
Licenses and Intellectual Property [Member]	'	'
Other Intangible Assets	'	'
Other Intangible Assets, Cost	19,990	19,950
Other Intangible Assets, Accumulated Amortization	4,051	3,260
Other Intangible Assets, Net Book Value	15,939	16,690
Other [Member]	'	'
Other Intangible Assets	'	'
Other Intangible Assets, Cost	8,892	8,843
Other Intangible Assets, Accumulated Amortization	1,238	821
Other Intangible Assets, Net Book Value	$7,654	$8,022

Contingencies_and_Guarantees_D

Contingencies and Guarantees (Details) (USD $)	6 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Accrual for product warranties	'	'
Balance at the beginning of period	$7	$32
Warranty redemptions	-5	-77
Warranties issued	5	52
Balance at the end of period	$7	$7

Condensed_Consolidated_Stateme7

Condensed Consolidated Statement of Operations Supplemental Information (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
	Theaters		Film
	Exhibitor		Theaters
	Film		Exhibitor
Selling Expenses	'	'	'	'
Deferred direct selling cost and direct advertising and marketing	$0.70	$0.40	$0.90	$0.70
Film exploitation costs, including advertising and marketing	2.2	1.4	3.6	2.4
Commissions recognized as cost and expenses	0.5	0.5	0.5	0.5
Direct advertising and marketing costs related to theater	0.5	0.5	0.7	0.7
Foreign Exchange	'	'	'	'
Foreign exchange translation gain related to monetary assets and liabilities	0.7	'	0.1	'
Foreign exchange translation gain related to monetary assets and liabilities	'	'	'less than	'
Collaborative Arrangements	'	'	'	'
Non-cancellable term of joint revenue sharing arrangements	'	'	'10 to 13 years	'
Total number of exhibitors under joint revenue sharing agreements	39	'	39	'
Total number of theater systems under joint revenue sharing agreements	654	'	654	'
Total number of operating theaters under joint revenue sharing agreement	408	'	408	'
Amounts attributable to transactions arising between the company and its customers under joint revenue sharing arrangements	19.4	18.3	30.2	27.7
IMAX DMR films exhibited in the current period	'	'	26	'
Number of films to be released in the remainder of the current year	'	'	9	'
Amounts attributable to transactions arising between the company and its customers under IMAX DMR arrangements	24	26	39.2	40.3
Number of significant co-produced film arrangement	1	'	1	'
Number of other co-produced film arrangements	6	'	6	'
Variable interest entity, non-consolidated, Assets	0.5	'	0.5	'
Variable interest entity, non-consolidated, Liabilities	0.5	'	0.5	'
Amounts attributable to transactions between the company and other parties included in cost and expense	$1.30	$1	$1.90	$2.10
Maximum [Member]	'	'	'	'
Collaborative Arrangements	'	'	'	'
Non-cancellable term of joint revenue sharing arrangements	13	'	13	'
Percentage of the gross box-office receipts of the film for recovering digital re-mastering cost	15.00%	'	15.00%	'
Minimum [Member]	'	'	'	'
Collaborative Arrangements	'	'	'	'
Non-cancellable term of joint revenue sharing arrangements	10	'	10	'
Percentage of the gross box-office receipts of the film for recovering digital re-mastering cost	10.00%	'	10.00%	'

Condensed_Consolidated_Stateme8

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Decrease (increase) in:	'	'
Accounts receivable	($398)	($20,661)
Financing receivables	2,074	-5,994
Inventories	-7,012	-1,717
Prepaid expenses	-842	-739
Commissions and other deferred selling expenses	-686	-131
Insurance recoveries	10,958	112
Other assets	-602	-74
Increase (decrease) in:	'	'
Accounts payable	-6,908	4,132
Accrued and other Liabilities	-11,005	109
Deferred revenue	11,202	-38
Changes in other non-cash operating assets and liabilities	-3,219	-25,001
Cash payments	'	'
Income taxes	3,729	301
Interest	$0	$347

Receivable_Provisions_Net_of_R2

Receivable Provisions Net of Recoveries (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Receivable Provisions, Net of Recoveries [Abstract]	'	'	'	'
Accounts receivable provisions, net of recoveries	$329	($45)	$449	($45)
Financing receivables, net of recoveries	0	100	167	100
Receivable provisions, net of recoveries	$329	$55	$616	$55

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Unrealized change in cash flow hedging instruments	($242)	$129	($159)	$206
Realized change in cash flow hedging instruments upon settlement	-66	-22	-1	11
Other-than-temporary impairment of available-for-sale investment	-45	0	-45	0
Foreign currency translation adjustments	7	-61	40	26
Amortization of actuarial loss on defined benefit plan	0	-29	0	-58
Gain on curtailment of postretirement benefit plan	0	0	0	-100
Income tax effect on comprehensive income (loss)	($346)	$17	($165)	$85

Capital_Stock_Details

Capital Stock (Details) (Employee Stock Option [Member])	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Weighted average fair value of common share granted to employees	'	'	'
Average risk-free interest rate	1.10%	2.50%	1.34%
Expected volatility	40.00%	37.50%	40.00%
Dividend yield	0.00%	0.00%	0.00%
Maximum [Member]	'	'	'
Weighted average fair value of common share granted to employees	'	'	'
Expected option life (in years)	'4 years 7 months 17 days	'5 years 9 months 25 days	'4 years 7 months 17 days
Annual termination probability	8.52%	8.40%	8.52%
Minimum [Member]	'	'	'
Weighted average fair value of common share granted to employees	'	'	'
Expected option life (in years)	'4 years 7 months 17 days	'4 years 5 months 23 days	'4 years 7 months 13 days
Annual termination probability	8.46%	0.00%	8.46%

Segmented_Information_Details

Segmented Information (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues	'	'	'	'
Revenues	$79,145	$81,713	$127,342	$131,379
Gross margins	'	'	'	'
Gross margins	47,794	43,635	74,202	69,825
Imax Theater Systems Total [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	46,032	47,080	72,843	76,983
Gross margins	'	'	'	'
Gross margins	27,748	27,396	42,805	44,800
Imax Systems [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	17,996	20,792	25,756	33,530
Gross margins	'	'	'	'
Gross margins	11,589	10,729	16,362	18,943
Theater System Maintenance [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	8,673	7,952	16,868	15,741
Gross margins	'	'	'	'
Gross margins	2,781	3,160	5,782	6,214
Joint Revenue Sharing Arrangements [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	19,363	18,336	30,219	27,712
Gross margins	'	'	'	'
Gross margins	13,378	13,507	20,661	19,643
Films Total [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	29,383	31,064	49,257	49,047
Gross margins	'	'	'	'
Gross margins	19,592	15,558	31,381	24,542
Production and IMAX DMR [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	24,050	25,952	39,235	40,307
Gross margins	'	'	'	'
Gross margins	18,634	14,936	29,708	24,149
Distribution [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	2,942	2,185	4,405	4,672
Gross margins	'	'	'	'
Gross margins	594	309	784	512
Post Production [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	2,391	2,927	5,617	4,068
Gross margins	'	'	'	'
Gross margins	364	313	889	-119
Others [Member]	'	'	'	'
Revenues	'	'	'	'
Revenues	3,730	3,569	5,242	5,349
Gross margins	'	'	'	'
Gross margins	$454	$681	$16	$483

Employees_Pension_and_Postreti2

Employees Pension and Postretirement Benefits (Details) (Pension Plans, Defined Benefit [Member], USD $)	3 Months Ended		6 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Pension Plans, Defined Benefit [Member]	'	'	'	'	'
Amounts Accrued	'	'	'	'	'
Obligation, beginning of period	'	'	$18,284	$20,366	$20,366
Interest cost	66	49	132	98	195
Actuarial gain	'	'	0	'	-2,277
Obligation, end of period and unfunded status	18,416	'	18,416	'	18,284
Pension Expense	'	'	'	'	'
Interest cost	66	49	132	98	195
Amortization of actuarial loss	0	111	0	222	'
Pension expense	$66	$160	$132	$320	'

Financial_Instruments_Details

Financial Instruments (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other Financial Instrument	'	'
Net financed sales receivable	$92,133	$93,493
Net investment in sales-type leases	12,736	13,617
Carrying (Reported) Amount, Fair Value Disclosure [Member]	'	'
Other Financial Instrument	'	'
Net financed sales receivable	92,133	93,493
Net investment in sales-type leases	12,736	13,617
Available-for-sale investment	700	1,000
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Designated as Hedging Instrument [Member]	'	'
Other Financial Instrument	'	'
Foreign exchange contracts	209	-421
Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Other Financial Instrument	'	'
Net financed sales receivable	91,055	92,043
Net investment in sales-type leases	12,414	13,214
Available-for-sale investment	700	1,000
Estimate of Fair Value, Fair Value Disclosure [Member] | Designated as Hedging Instrument [Member]	'	'
Other Financial Instrument	'	'
Foreign exchange contracts	$209	($421)

NonControlling_Interests_Detai

Non-Controlling Interests (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Non-controlling Interests	'	'	'	'
Issuance of subsidiary shares to a non-controlling interest	'	'	$40,491	$0
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest	'	'	-3,556	0
Net income (loss)	472	0	472	0
Accretion charges associated with redeemable common stock	'	'	142	'
IMAX China Noncontrolling Interest	'	'	'	'
Non-controlling Interests	'	'	'	'
Balance as at December 31, 2013	'	'	0	'
Issuance of subsidiary shares to a non-controlling interest	'	'	40,000	'
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest	'	'	-2,843	'
Net income (loss)	'	'	543	'
Other comprehensive loss, net of tax	'	'	-3	'
Accretion charges associated with redeemable common stock	'	'	142	'
Balance as at June 30, 2014	37,839	'	37,839	'
Other Noncontrolling Interest [Member]	'	'	'	'
Non-controlling Interests	'	'	'	'
Balance as at December 31, 2013	'	'	0	'
Issuance of subsidiary shares to a non-controlling interest	'	'	491	'
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest	'	'	-713	'
Net income (loss)	'	'	-71	'
Balance as at June 30, 2014	($293)	'	($293)	'

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Discontinued Operations And Disposal Groups [Abstract]	'	'	'	'
Services revenue	$0	$580	$35	$783
Services cost of sales applicable to revenues	0	-639	537	-993
Tax (expense) recovery	0	20	-217	71
Net (loss) income from discontinued operations	$0	($39)	$355	($139)

Subsequent_Event_Details

Subsequent Event (Details)	Apr. 08, 2014
Subsequent Events [Abstract]	'
Sale and issuance of the shares in IMAX China to third party	20.00%

Financing_Receivables_Details_

Financing Receivables (Details Textuals)	Jun. 30, 2014	Dec. 31, 2013
Financing Receivables (Textuals) [Abstract]	'	'
Financed sale receivables, Weighted average effective interest rate	10.20%	9.80%

Inventories_Details_Textuals

Inventories (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Inventories (Textuals) [Abstract]	'	'	'	'	'
Finished goods inventory with title passed to customer	$700,000	'	$700,000	'	$1,700,000
Write-downs for excess and obsolete inventory	$36,000	$0	$43,000	$0	'

Other_Intangible_Assets_Detail1

Other Intangible Assets (Details 1) (USD $)	Jun. 30, 2014
In Thousands, unless otherwise specified
Other Intangible Assets [Abstract]	'
2014 (six months remaining)	$1,468
2015	2,833
2016	2,654
2017	2,654
2018	$2,654

Other_Intangible_Assets_Detail2

Other Intangible Assets (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Other Intangible Assets (Textuals) [Abstract]	'	'	'	'
Other Intangible Asset, comprised mainly of ERP System	$8.90	'	$8.90	'
Acquisition of other intangible assets, cost	'	'	0.5	'
Weighted average amortization period for additions to other intangible assets	'	'	'10 years	'
Costs incurred to renew or extend the term of acquired other intangible assets	'less than	'less than	'less than	'
Costs incurred to renew or extend the term of acquired other intangible assets	$0.10	$0.10	$0.10	$0.10

Credit_Facility_Details_Textua

Credit Facility (Details Textuals) (USD $)

Apr. 08, 2014

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2014

Dec. 31, 2013

Feb. 07, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

In Thousands, unless otherwise specified

Wells Fargo Foreign Exchange Facility [Member]

Bank of Montreal Facilities [Member]

Bank of Montreal Facilities [Member]

Prior Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Credit Facility [Member]

Letter Of Credit And Apg [Member]

Letter Of Credit And Apg [Member]

Revolving Loan [Member]

Revolving Loan [Member]

Revolving Loan [Member]

Revolving Loan [Member]

Credit Facility (Textuals) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Credit Facility Expiration Date

'

'

'

'

'

7-Feb-18

'

'

'

'

'

'

Maximum borrowing capacity

'

'

'

'

$110,000

'

'

$200,000

'

'

'

'

Sale and issuance of the shares in IMAX China to third party

20.00%

'

'

'

'

'

'

'

'

'

'

'

Effective interest rate

'

'

'

'

'

'

'

'

0.00%

2.19%

0.00%

2.40%

Current borrowing capacity

'

'

10,000

10,000

'

200,000

200,000

'

'

'

'

'

Amounts drawn

'

'

'

'

'

0

0

'

'

'

'

'

Settlement risk on its foreign currency forward contracts

'

0

'

'

'

'

'

'

'

'

'

'

Notional Amount of arrangements entered into

'

23,500

'

'

'

'

'

'

'

'

'

'

Letters of credit and advance payment guarantees

'

'

300

300

'

'

'

'

'

'

'

'

Revolving Loan

'

'

'

'

'

$0

$0

'

'

'

'

'

Commitments_Details_Textuals

Commitments (Details Textuals) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Other Commitments [Line Items]	'
Amount capitalized to date on the construction of new office facility	$14.70
Expected completion date of office facility under construction	'2015
Minimum [Member]	'
Other Commitments [Line Items]	'
Committed investment for the construction of new office facility	45
Maximum [Member]	'
Other Commitments [Line Items]	'
Committed investment for the construction of new office facility	$50

Contingencies_and_Guarantees_D1

Contingencies and Guarantees (Details Textuals) (USD $)	0 Months Ended				1 Months Ended	6 Months Ended
	4-May-12	Dec. 02, 2011	Mar. 27, 2008	Sep. 20, 2006	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2013	Mar. 02, 2013	Jan. 26, 2012	Aug. 24, 2007
Contingencies And Guarantees Disclosure (Textuals) [Abstract]	'	'	'	'	'	'	'	'	'	'
Interim awards issued in favor of Company	'	'	'	'	'	'	'	'	'	$9,400,000
Final Award in favor of company	'	'$30,000 to cover the costs of the application	'Amount of $11,300,000 plus an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid	'	'	'	'	'	'	'
Final award in favour of Company	15,500,000	'	'	'	6,000,000	'	'	'	'	'
Damages sought	'	'	'	'210,000,000	'	'6,000,000 Chinese Yuan Renminbi plus costs	'	'	'	'
The arbitrator issued a final award in damages	'	'	'	'	'	'	'	'	12,000,000	'
Disgorgement Of Profits Damages Awarded	'	'	'	'	456,000	456,000	'	'	'	'
Punitive Damages Awarded	'	'	'	'	50,000	50,000	'	'	'	'
Costs Awarded	'	'	'	'	300,000	300,000	'	'	'	'
Indemnification of its directors/officers	'	'	'	'	0	0	0	'	'	'
Other Indemnification	'	'	'	'	'	'0	'	'	'	'
Financial Guarantees	'	'	'	'	$0	$0	'	'	'	'
Reduction In Canadian Class Action Lawsuit Size	'	'	'	'	'	'	'	85.00%	'	'

Condensed_Consolidated_Stateme9

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details 1) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Summary of Depreciation and amortization	'	'
Film assets	$5,343	$10,020
Property, plant and equipment	'	'
Joint revenue sharing arrangements	5,852	5,819
Other property, plant and equipment	2,676	2,454
Other intangible assets	1,468	1,397
Other assets	343	286
Deferred financing costs	263	225
Depreciation and amortization	$15,945	$20,201

Recovered_Sheet1

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details 2) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Write-downs, net of recoveries	'	'	'	'
Impairment of available-for-sale investment	$650	$0	$650	$0
Accounts receivable	'	'	449	-45
Financing receivables	'	'	167	100
Property, plant and equipment	'	'	270	0
Inventories	36	0	43	0
Write-downs, net of recoveries	'	'	$1,579	$55

Recovered_Sheet2

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details Textual) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Condensed Consolidated Statements of Cash Flows Supplemental Information (Textuals) [Abstract]	'	'
Payments for variable stock based compensation	$0	$1

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Deferred Tax Assets	'	'
Deferred income tax asset after valuation allowance	$21.20	$24.30
Deferred income tax asset before valuation allowance	26	29.1
Valuation allowance	$4.80	$4.80

Capital_Stock_Details_1

Capital Stock (Details 1) (Options Non Employees [Member])	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2013
Options Non Employees [Member]	'	'
Options to Non-Employees	'	'
Average risk-free interest rate	1.64%	1.64%
Contractual option life (in years)	'7 years 0 months 0 days	'7 years 0 months 0 days
Expected volatility	40.00%	40.00%
Dividend yield	0.00%	0.00%

Capital_Stock_Details_2

Capital Stock (Details 2) (Employee Stock Option [Member], USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Employee Stock Option [Member]	'	'	'	'
Option activity under the Stock Option Plan	'	'	'	'
Options outstanding, beginning of period	'	'	6,263,121	7,441,068
Options outstanding, per share beginning of period	'	'	$21.11	$18.48
Options granted	'	'	828,353	192,112
Weighted average fair value of options granted	'	'	$27.44	$25.46
Exercised	'	'	-505,187	-579,681
Weighted average fair value of options exercised	'	'	$5.26	$6.89
Forfeited	'	'	-10,000	-69,658
Weighted average fair value of options forfeited	'	'	$18.98	$26.58
Options cancelled	-17,787	-300	-23,787	-1,550
Weighted average fair value of options cancelled	'	'	$33.60	$28.78
Options outstanding, end of period	6,552,500	6,982,291	6,552,500	6,982,291
Options outstanding, per share end of period	$23.09	$19.56	$23.09	$19.56
Options exercisable, end of period	3,656,730	3,477,935	3,656,730	3,477,935
Options exercisable, weighted average exercise price	$21.35	$17.17	$21.35	$17.17

Capital_Stock_Details_3

Capital Stock (Details 3) (Restricted Share Units (RSUs) [Member], USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Restricted Share Units (RSUs) [Member]	'	'
Resticted Share Units activity under the LTIP	'	'
RSUs outanding, beginning of period	264,140	0
RSUs outstanding, per share beginning of period	$26.14	$0
RSUs granted	482,588	277,198
Weighted average grant date fair value of RSUs granted	$27.41	$26.28
RSUs vested and settled	-104,612	-39,761
Weighted average grant date fair value RSUs vested and settled	$26.13	$26.28
RSUs outanding, end of period	642,116	237,437
RSUs outstanding, per share end of period	$27.09	$26.28

Capital_Stock_Details_4

Capital Stock (Details 4) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Net income attributable to Common Shareholders	$13,307	$11,816	$13,886	$14,677	'
Less: Accretion charges associated with redeemable common stock	-142	0	-142	0	'
Net income applicable to Common Shareholders	$13,165	$11,816	$13,744	$14,677	'
Weighted average number of common shares:	'	'	'	'	'
Issued and outstanding, beginning of period	67,957,167	66,866,076	67,841,233	66,482,425	68,423,128
Weighted average number of shares issued during the period	270,658	85,974	226,644	316,943	'
Weighted average number of shares used in computing basic income per share	68,227,825	66,952,050	68,067,877	66,799,368	'
Assumed exercise of stock options and RSUs, net of shares assumed repurchased	1,224,269	1,940,877	1,380,039	1,970,463	'
Weighted average number of shares used in computing diluted income per share	69,452,094	68,892,927	69,447,916	68,769,831	'

Capital_Stock_Details_5

Capital Stock (Details 5) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Movement of Shareholders Equity	'	'	'	'
Balance as at December 31, 2013	'	'	$319,585	'
Net income attributable to Common Shareholders	13,307	11,816	13,886	14,677
Adjustment to capital stock for cash received from issuance of common shares	'	'	2,657	'
Adjustment to capital stock for issuance of common shares for vested RSUs	'	'	2,000	'
Adjustment to capital stock for fair value of stock options exercised at date of grant	'	'	641	'
Adjustment to other equity for employee stock options granted	'	'	4,540	'
Adjustment to other equity for non-employee stock options granted	'	'	149	'
Adjustment to other equity for fair value of stock options exercised at date of grant	'	'	-641	'
Adjustment to other equity for RSUs granted	3,335	'	3,335	'
Adjustment to other equity for RSUs vested	-2,792	'	-2,792	'
Adjustment to other equity for the excess tax benefits from RSUs	'	'	13	'
Adjustment for accretion charges associated with redeemable common stock	'	'	-142	'
Adjustment to accumulated other comprehensive loss for unrealized net gain from cash flow hedging instruments	'	'	127	'
Adjustment to accumulated other comprehensive loss for the realization of cash flow hedging net loss upon settlement	'	'	504	'
Adjustment to accumulated other comprehensive loss for an other-than-temporary impairment of available-for-sale investment	350	0	350	0
Adjustment to accumulated other comprehensive loss for foreign currency translation adjustments	'	'	-175	'
Tax effect of movement in other comprehensive income	346	-17	165	-85
Balance as at June 30, 2014	$343,872	'	$343,872	'

Capital_Stock_Details_Textual

Capital Stock (Details Textual) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2013
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	$4.70	$3.10	$7.90	$5.90	'	'
Antidilutive shares issuable upon exercise of stock options	4,325,037	'	4,205,083	'	'	'
Employee Stock Option [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	2.2	2.2	4.4	4.4	'	'
Reserved common shares for future issuance	9,887,137	'	9,887,137	'	'	10,530,723
Options outstanding	6,552,500	6,982,291	6,552,500	6,982,291	7,441,068	6,263,121
Options outstanding, weighted average exercise price	$23.09	$19.56	$23.09	$19.56	$18.48	$21.11
Options common shares were vested and exercisable	3,656,730	'	3,656,730	'	'	'
Options fully vested or expected to vest	6,201,893	'	6,201,893	'	'	'
Options fully vested or expected to vest, weighted average exercise price	$22.96	'	$22.96	'	'	'
Options fully vested or expected to vest, weighted average remaining contractual life	'	'	'4 years 9 months 18 days	'	'	'
Options fully vested or expected to vest, aggregate intrinsic value	37.1	'	37.1	'	'	'
Weighted average remaining contractual life of exercisable option	'	'	'4 years 6 months 0 days	'	'	'
Options exercisable intrinsic value	27.7	'	27.7	'	'	'
Intrinsic value of options exercised	9	3.8	11.1	11	'	'
Options granted	'	'	828,353	192,112	'	'
Options exercisable	3,656,730	3,477,935	3,656,730	3,477,935	'	'
Options exercisable, weighted average exercise price	$21.35	$17.17	$21.35	$17.17	'	'
Weighted average fair value of options granted	'	$6.51	$8.33	$6.54	'	'
Weighted average fair value of options granted	'not applicable	'	'	'	'	'
Options cancelled	17,787	300	23,787	1,550	'	'
Antidilutive shares issuable upon exercise of stock options	4,205,083	'	4,205,083	'	'	'
Tax benefits realized stock options	'	'	0.9	'	'	'
Options Non Employees [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	'less than	'	'less than	'	'	'
Share-based compensation costs recorded for the period	0.1	0.1	0.1	0.1	'	'
Options outstanding	54,251	108,001	54,251	108,001	'	'
Options outstanding, weighted average exercise price	$13.71	$14.08	$13.71	$14.08	'	'
Options fully vested or expected to vest, weighted average remaining contractual life	'	'	'7 years 0 months 0 days	'	'	'
Options fully vested or expected to vest, aggregate intrinsic value	0.7	0.6	0.7	0.6	'	'
Options granted	0	2,500	0	2,500	'	'
Options granted to purchase the company's common stock, average exercise price	'	$26.28	'	$26.28	'	'
Options exercisable	41,576	41,384	41,576	41,384	'	'
Options exercisable, weighted average exercise price	$11.15	$11.36	$11.15	$11.36	'	'
Weighted average fair value of options granted	'	$11.50	'	$11.50	'	'
Amount of stock options or rights included in accrued liabilities	'less than	'	'less than	'	'	'
Amount of stock options or rights included in accrued liabilities	0.1	'	0.1	'	'	0.1
Employee Stock Option China Incentive Plan [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	0.1	0.1	0.2	0.1	'	'
Options outstanding	152,644	'	152,644	'	'	146,623
Options outstanding, weighted average exercise price	$22.58	'	$22.58	'	'	$22.39
Weighted average remaining contractual life of exercisable option	'	'	'7 years 0 months 0 days	'	'	'
Options granted	0	0	6,021	0	146,623	'
Options granted to purchase the company's common stock, average exercise price	$0	'	$27.20	'	$22.39	'
Common share options subject to vesting based on performance commitment	152,644	'	152,644	'	'	'
Weighted average fair value of options granted	$0	'	$7.02	'	'	'
Fair value of options outstanding	1.6	'	1.6	'	'	'
Share-based compensation costs, not yet recognized, period for recognition	'	'	'5 years 0 months 0 days	'	'	'
Restricted Share Units (RSUs) [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number	642,116	237,437	642,116	237,437	0	264,140
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period	'	'	482,588	277,198	'	'
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value	$27.09	$26.28	$27.09	$26.28	$0	$26.14
Antidilutive shares issuable upon exercise of stock options	119,954	'	0	'	'	'
Share-based compensation costs, not yet recognized, period for recognition	'	'	'3 years 1 month 6 days	'	'	'
Share-based compensation costs, not yet recognized	13.4	'	13.4	'	'	'
Tax benefits realized	0.2	'	0.5	'	'	'
Restricted Stock Unit Contingent Right	'	'	1	'	'	'
Restricted Stock Unit Economic Equivalent	'	'	1	'	'	'
Common shares issued in connection with vested RSUs	61,386	'	104,524	'	'	'
Common shares issued from treasury in connection with vested RSUs	'	'	76,708	'	'	'
Common shares purchased in open market by trustee in connection with vested RSUs	'	'	27,816	'	'	'
Restricted Share Units (RSUs) [Member] | Non Employee [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	'less than	'less than	'less than	'less than	'	'
Share-based compensation costs recorded for the period	0.1	0.1	0.1	0.1	'	'
Restricted Share Units (RSUs) [Member] | Employee [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	2.4	1.1	3.3	1.1	'	'
Stock Appreciation Rights [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Share-based compensation costs recorded for the period	'	-0.1	'	0.3	'	'
Options forfeited	'	0	'	0	'	'
Options cancelled	'	0	'	0	'	'
Cash paid in settlement	'	$0	'	$1	'	'
Number of rights settled in cash	'	0	'	50,000	'	'
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period	'	'	0	0	'	'
Average exercise price of cash settled rights	'	$0	'	$6.86	'	'
Share based compensation arrangement by share based payment award equity instruments other than options exercisable	0	'	0	'	'	0
Maximum [Member] | Employee Stock Option [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Annual termination probability	'	8.52%	8.40%	8.52%	'	'
Maximum [Member] | Restricted Share Units (RSUs) [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Stock based awards vesting period	'	'	'4 years 0 months 0 days	'	'	'
Annual termination probability	'	'	9.46%	'	'	'
Minimum [Member] | Employee Stock Option [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Annual termination probability	'	8.46%	0.00%	8.46%	'	'
Minimum [Member] | Restricted Share Units (RSUs) [Member]	'	'	'	'	'	'
Capital Stock (Textuals) [Abstract]	'	'	'	'	'	'
Stock based awards vesting period	'	'	'1 year 0 months 0 days	'	'	'
Annual termination probability	0.00%	'	0.00%	'	'	'

Segmented_Information_Details_

Segmented Information (Details 1) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Geographical Information	'	'	'	'
Revenues	$79,145	$81,713	$127,342	$131,379
United States [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	32,528	42,020	52,212	63,371
Canada [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	2,507	3,702	4,632	5,451
Greater China [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	17,847	10,931	28,356	21,943
Asia (excluding Greater China) [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	8,410	8,158	12,696	12,149
Western Europe [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	7,411	5,689	12,407	9,079
Russia and the CIS [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	5,105	6,913	7,451	11,852
Latin America [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	3,806	3,214	6,062	4,634
Rest of the World [Member]	'	'	'	'
Geographical Information	'	'	'	'
Revenues	$1,531	$1,086	$3,526	$2,900

Segmented_Information_Details_1

Segmented Information (Details Textual) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
			Segments
Segment Reporting (Textuals) [Abstract]	'	'	'	'
Marketing and commission costs	$0.70	$0.40	$0.90	$0.70
Disclosure on Geographic Areas, Description of Revenue from External Customers	'	'	'No single country in the Rest of the World, Western Europe, Latin America and Asia (excluding Greater China) classifications comprise more than 10% of the total revenue.	'
Percentage of total revenues represented by largest customer	16.50%	14.30%	16.40%	14.30%
Number of Reportable Segments	'	'	7	'
Imax Systems [Member]	'	'	'	'
Segment Reporting (Textuals) [Abstract]	'	'	'	'
Marketing and commission costs	0.7	0.4	0.9	0.7
Joint Revenue Sharing Arrangements [Member]	'	'	'	'
Segment Reporting (Textuals) [Abstract]	'	'	'	'
Advertising, marketing and commission costs	1	0.9	1.2	1.1
Production and Imax Dmr [Member]	'	'	'	'
Segment Reporting (Textuals) [Abstract]	'	'	'	'
Marketing costs	2	1.4	3.2	2.3
Distribution [Member]	'	'	'	'
Segment Reporting (Textuals) [Abstract]	'	'	'	'
Marketing costs	$0.20	$0.10	$0.40	$0.10
Marketing costs	'	'less than	'	'

Employees_Pension_and_Postreti3

Employees Pension and Postretirement Benefits (Details 1) (USD $)	Jun. 30, 2014
In Thousands, unless otherwise specified
SERP Benefits [Member]	'
Schedule of expected benefit payments	'
2014 (six months remaining):	$0
2015	0
2016	0
2017	19,228
2018	0
Thereafter	0
Total expected future benefit payment	19,228
Postretirement Benefits Executive [Member]	'
Schedule of expected benefit payments	'
2014 (six months remaining):	20
2015	22
2016	24
2017	29
2018	33
Thereafter	274
Total expected future benefit payment	402
Postretirement Benefits Canadian Employees [Member]	'
Schedule of expected benefit payments	'
2014 (six months remaining):	76
2015	89
2016	99
2017	110
2018	116
Thereafter	1,873
Total expected future benefit payment	$2,363

Employees_Pension_and_Postreti4

Employees Pension and Postretirement Benefits (Details Textual) (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Feb. 21, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

SERP Benefits [Member]

SERP Benefits [Member]

SERP Benefits [Member]

Postretirement Benefits Executive [Member]

Postretirement Benefits Executive [Member]

Postretirement Benefits Executive [Member]

Postretirement Benefits Executive [Member]

Postretirement Benefits Executive [Member]

Postretirement Benefits Canadian Employees [Member]

Postretirement Benefits Canadian Employees [Member]

Postretirement Benefits Canadian Employees [Member]

Postretirement Benefits Canadian Employees [Member]

Postretirement Benefits Canadian Employees [Member]

Postretirement Benefits Canadian Employees [Member]

Canadian Plan [Member]

Canadian Plan [Member]

Canadian Plan [Member]

Canadian Plan [Member]

Us Internal Revenue Code [Member]

Us Internal Revenue Code [Member]

Us Internal Revenue Code [Member]

Us Internal Revenue Code [Member]

Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Postretirement benefits obligation

'

'

'

'

$18,416,000

$18,284,000

$20,366,000

$400,000

'

$400,000

'

$400,000

'

$2,400,000

'

$2,400,000

'

$2,300,000

'

'

'

'

'

'

'

'

Maximum amount of Postretirement benefit expensed

'

'

'

'

'

'

'

100,000

100,000

100,000

100,000

'

'

100,000

100,000

100,000

100,000

'

'

'

'

'

'

'

'

'

Maximum amount of Postretirement benefit expensed

'

'

'

'

'

'

'

'less than

'less than

'less than

'less than

'

'

'less than

'less than

'less than

'less than

'

'

'

'

'

'

'

'

'

Companies contribution and expenses

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

400,000

700,000

700,000

100,000

100,000

200,000

200,000

Expected interest costs in the remainder of the year

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Pre-tax curtailment gain recognized

0

0

0

2,185,000

'

'

'

'

'

'

'

'

2,185,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction in postretirement liability

'

'

'

'

'

'

'

'

'

'

'

'

$2,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Employees Pension and Postretirement Benefits (Additional Textuals) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum percentage of base salary contributed to Pension Plan by Company

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financial_Instruments_Details_

Financial Instruments (Details 1) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Summary of changes in the fair value	'	'
Beginning balance, January 1	$1,000	$1,350
Transfers into/out of Level 3	0	0
Total gains or losses (realized/unrealized) Included in earnings	-650	0
Total gains or losses (realized/unrealized) Change in other comprehensive income	350	0
Purchases, issuances, sales and settlements	0	0
Ending balance, June 30,	700	1,350
The amount of total gains or losses for the period included in earnings attributable change in to the unrealized gains or losses relating to assets still held at the reporting date	($650)	$0

Financial_Instruments_Details_1

Financial Instruments (Details 2) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Recorded investment in financing receivables by credit quality indicator	'	'
Minimum Lease Payments	$13,701	$14,423
Financed Sales Receivables	92,626	93,729
Total	106,327	108,152
In Good Standing [Member]	'	'
Recorded investment in financing receivables by credit quality indicator	'	'
Minimum Lease Payments	11,435	12,318
Financed Sales Receivables	90,900	89,017
Total	102,335	101,335
Credit Watch Member [Member]	'	'
Recorded investment in financing receivables by credit quality indicator	'	'
Minimum Lease Payments	0	420
Financed Sales Receivables	333	3,895
Total	333	4,315
Pre-Approved Transactions [Member]	'	'
Recorded investment in financing receivables by credit quality indicator	'	'
Minimum Lease Payments	294	288
Financed Sales Receivables	532	0
Total	826	288
Transactions Suspended [Member]	'	'
Recorded investment in financing receivables by credit quality indicator	'	'
Minimum Lease Payments	1,972	1,397
Financed Sales Receivables	861	817
Total	$2,833	$2,214

Financial_Instruments_Details_2

Financial Instruments (Details 3) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Investment In Financing Receivables On Nonaccrual Status	'	'
Net investment in leases recorded investment	$2,265	$1,684
Net investment in leases related allowance	-965	-606
Net financed sales receivables recorded investment	861	817
Net financed sales receivables related allowance	-493	-236
Total recorded investment	3,126	2,501
Total related allowance	($1,458)	($842)

Financial_Instruments_Details_3

Financial Instruments (Details 4) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	$2,168	'	$2,946	'	'	'
30-89 Days	1,344	'	1,429	'	'	'
90+ Days	5,272	'	3,859	'	'	'
Billed Financing Receivables	8,784	'	8,234	'	'	'
Related Unbilled Recorded Investment	97,543	'	99,918	'	'	'
Total Recorded Investment	106,327	'	108,152	'	'	'
Related Allowances	-1,458	'	-1,042	'	'	'
Recorded Investment Net of Allowances	104,869	'	107,110	'	'	'
Net Investment in Leases [Member]	'	'	'	'	'	'
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	257	'	444	'	'	'
30-89 Days	178	'	218	'	'	'
90+ Days	1,141	'	841	'	'	'
Billed Financing Receivables	1,576	'	1,503	'	'	'
Related Unbilled Recorded Investment	12,125	'	12,920	'	'	'
Total Recorded Investment	13,701	'	14,423	'	'	'
Related Allowances	-965	-806	-806	-1,230	-1,130	-1,130
Recorded Investment Net of Allowances	12,736	'	13,617	'	'	'
Net Financed Sales Receivables [Member]	'	'	'	'	'	'
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	1,911	'	2,502	'	'	'
30-89 Days	1,166	'	1,211	'	'	'
90+ Days	4,131	'	3,018	'	'	'
Billed Financing Receivables	7,208	'	6,731	'	'	'
Related Unbilled Recorded Investment	85,418	'	86,998	'	'	'
Total Recorded Investment	92,626	'	93,729	'	'	'
Related Allowances	-493	-488	-236	-66	-66	-66
Recorded Investment Net of Allowances	92,133	'	93,493	'	'	'
Financing Receivables Continue To Accrue Finance Income [Member]	'	'	'	'	'	'
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	548	'	618	'	'	'
30-89 Days	532	'	577	'	'	'
90+ Days	2,684	'	2,261	'	'	'
Billed Financing Receivables	3,764	'	3,456	'	'	'
Related Unbilled Recorded Investment	21,382	'	24,147	'	'	'
Related Allowances	0	'	-200	'	'	'
Recorded Investment Net of Allowances	25,146	'	27,403	'	'	'
Financing Receivables Continue To Accrue Finance Income [Member] | Net Investment in Leases [Member]	'	'	'	'	'	'
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	108	'	168	'	'	'
30-89 Days	145	'	108	'	'	'
90+ Days	469	'	205	'	'	'
Billed Financing Receivables	722	'	481	'	'	'
Related Unbilled Recorded Investment	4,796	'	4,865	'	'	'
Related Allowances	0	'	-200	'	'	'
Recorded Investment Net of Allowances	5,518	'	5,146	'	'	'
Financing Receivables Continue To Accrue Finance Income [Member] | Net Financed Sales Receivables [Member]	'	'	'	'	'	'
Financing Receivable, Recorded Investment, Past Due [Line Items]	'	'	'	'	'	'
Accrued and Current	440	'	450	'	'	'
30-89 Days	387	'	469	'	'	'
90+ Days	2,215	'	2,056	'	'	'
Billed Financing Receivables	3,042	'	2,975	'	'	'
Related Unbilled Recorded Investment	16,586	'	19,282	'	'	'
Related Allowances	0	'	0	'	'	'
Recorded Investment Net of Allowances	$19,628	'	$22,257	'	'	'

Financial_Instruments_Details_4

Financial Instruments (Details 5) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Financing Receivable, Impaired [Line Items]	'	'	'	'
Recorded Investment	$525	$546	$525	$546
Unpaid Principal	0	269	0	269
Related Allowance	-493	-66	-493	-66
Average Recorded Investment	524	535	526	539
Interest Income Recognized	0	0	0	22
Net Financed Sales Receivables [Member]	'	'	'	'
Financing Receivable, Impaired [Line Items]	'	'	'	'
Impaired Financing Receivable with Related Allowance, Recorded Investment	525	188	525	188
Impaired Financing Receivable With Related Allowance, Unpaid Principal	0	220	0	220
Impaired Financing Receivable With Related Allowance, Average Recorded Investment	524	172	526	172
Impaired Financing Receivable With Related Allowance, Interest Income Recognized	0	0	0	0
Impaired Financing Receivable With No Related Allowance, Recorded Investment	0	358	0	358
Impaired Financing Receivable With No Related Allowance, Unpaid Principal	0	49	0	49
Impaired Financing Receivable With No Related Allowance, Average Recorded Investment	0	363	0	367
Impaired Financing Receivable With No Related Allowance, Interest Income Recognized	0	0	0	22
Related Allowance	($493)	($66)	($493)	($66)

Financial_Instruments_Detail_6

Financial Instruments (Detail 6) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
In Thousands, unless otherwise specified			Net Investment in Leases [Member]	Net Investment in Leases [Member]	Net Investment in Leases [Member]	Net Investment in Leases [Member]	Net Financed Sales Receivables [Member]	Net Financed Sales Receivables [Member]	Net Financed Sales Receivables [Member]	Net Financed Sales Receivables [Member]
Allowance for credit losses:	'	'	'	'	'	'	'	'	'	'
Beginning balance	$1,458	$1,042	$806	$1,130	$806	$1,130	$488	$66	$236	$66
Charge-offs	'	'	0	0	0	0	0	0	0	0
Provision	'	'	159	100	159	100	5	0	257	0
Ending balance	1,458	1,042	965	1,230	965	1,230	493	66	493	66
Ending balance: individually evaluated for impairment	'	'	965	1,230	965	1,230	493	66	493	66
Financing receivables:	'	'	'	'	'	'	'	'	'	'
Ending balance: individually evaluated for impairment	'	'	$13,701	$15,690	$13,701	$15,690	$92,626	$85,692	$92,626	$85,692

Financial_Instruments_Details_5

Financial Instruments (Details 7) (Foreign Exchange Contract [Member], Designated as Hedging Instrument [Member], USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]	'	'
Derivatives Fair Value [Line Items]	'	'
Derivative asset, Notional amount	$23,453	$23,555

Financial_Instruments_Details_6

Financial Instruments (Details 8) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair value of foreign exchange contracts	'	'
Derivative Asset, Fair Value	$209	($421)
Other Assets [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]	'	'
Fair value of foreign exchange contracts	'	'
Derivative Asset, Fair Value	423	0
Accrued Liabilities [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]	'	'
Fair value of foreign exchange contracts	'	'
Derivative Liability, Fair Value	($214)	($421)

Financial_Instruments_Details_7

Financial Instruments (Details 9) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Derivatives in Foreign Currency Hedging relationships	'	'	'	'
Derivative Gain (Loss) Recognized in OCI (Effective Portion)	$937	($498)	$127	($800)
Location of Derivative (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	-256	-82	-504	48
Fair Value Hedging [Member]	'	'	'	'
Derivatives in Foreign Currency Hedging relationships	'	'	'	'
Derivative Gain (Loss) Recognized in OCI (Effective Portion)	937	-498	127	-800
Foreign Exchange Forward [Member] | Fair Value Hedging [Member] | Selling General And Administrative Expenses [Member]	'	'	'	'
Derivatives in Foreign Currency Hedging relationships	'	'	'	'
Location of Derivative (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	($256)	($82)	($504)	$48

Financial_Instruments_Details_8

Financial Instruments (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Financial Instruments (Textuals) [Abstract]	'	'	'	'	'
Impairment of available-for-sale investment	$650,000	$0	$650,000	$0	'
Financing receivables indications of theaters with potential collection concerns	'	'	'60-89 days	'	'
Financing receivables indications of theaters to review and assess	'	'	'Once a theater’s aging exceeds 90 days, the Company’s policy is to review and assess collectibility on the theater’s past due accounts	'	'
Financing receivables indications of theaters with potential impairment	'	'	'Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer	'	'
Transfers into/out of Level 3	'	'	0	0	'
Financial Instruments Additional (Textuals) [Abstract]	'	'	'	'	'
Total carrying value of investments in new business ventures	4,900,000	'	4,900,000	'	5,800,000
Investment in preferred stock of other business venture - fair value	700,000	'	700,000	'	1,000,000
Investment in preferred stock of other business venture - cost	1,500,000	'	1,500,000	'	'
Impairment of available-for-sale investment	650,000	0	650,000	0	'
Adjustment to accumulated other comprehensive loss for an other-than-temporary impairment of available-for-sale investment	350,000	0	350,000	0	'
Adjustment directly to earnings for impairment of available-for-sale investment	300,000	'	300,000	'	'
Cost Method Investments Original Cost	2,500,000	'	2,500,000	'	2,500,000
Warrants	500,000	'	500,000	'	500,000
Variable Interest Entity, Not Primary Beneficiary [Member]	'	'	'	'	'
Financial Instruments Additional (Textuals) [Abstract]	'	'	'	'	'
Carrying value of equity investments	1,200,000	'	1,200,000	'	400,000
Carrying value of film production company VIEs	0	'	0	'	0
Variable Interest Entity, Not Primary Beneficiary [Member] | Equity Accounted Investment [Member]	'	'	'	'	'
Financial Instruments Additional (Textuals) [Abstract]	'	'	'	'	'
Gross revenues of investment new business ventures	1,400,000	800,000	2,300,000	4,200,000	'
Cost of revenue of investment new business ventures	800,000	3,200,000	1,700,000	6,900,000	'
Net loss on equity-accounted investments	200,000	4,300,000	1,000,000	6,500,000	'
Equity method investment, difference between carrying amount and underlying equity	300,000	'	300,000	'	'
Variable Interest Entity, Not Primary Beneficiary [Member] | New Equity Accounted Investment [Member]	'	'	'	'	'
Financial Instruments Additional (Textuals) [Abstract]	'	'	'	'	'
Carrying value of equity investments	'	'	'	'	$1,400,000

NonControlling_Interests_Detai1

Non-Controlling Interests (Details Textuals) (USD $)

6 Months Ended

0 Months Ended

6 Months Ended

0 Months Ended

6 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Apr. 08, 2019

Jun. 30, 2014

Apr. 08, 2014

Feb. 08, 2015

Apr. 08, 2014

Feb. 08, 2015

Apr. 08, 2019

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

IMAX China Noncontrolling Interest

Other Noncontrolling Interest [Member]

Other Noncontrolling Interest [Member]

Other Noncontrolling Interest [Member]

Class C Shares [Member]

Class C Shares [Member]

Class A Shares [Member]

Common Share [Member]

Film

Third Party [Member]

IMAX [Member]

Y

Redeemable Noncontrolling Interest [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Non-controlling interest description

'

'

'

'On April 8, 2014, the Company announced the investment in its Greater China business by CMC Capital Partners (“CMC”), an investment fund that is focused on media and entertainment, and FountainVest Partners (“FountainVest”), a China-focused private equity firm. The IMAX China investment provides for the sale and issuance of 20.0% of the shares in IMAX China to entities owned and controlled by CMC and FountainVest, with the intent of further strengthening the Company’s competitive position in China. Pursuant to the transaction, IMAX China issued the investors 337,500 Common C Shares of par value $0.01 each in the authorized capital of IMAX China (the “Class C Shares”) for an aggregate subscription price of $40.0 million (the “First Closing”) on April 8, 2014 (the “First Completion Date”), and subject to certain conditions, IMAX China agreed to issue to the investors another 337,500 Class C Shares for an aggregate subscription price of $40.0 million (the “Second Closing”) on February 8, 2015 (the “Second Completion Date”). IMAX China remains a consolidated subsidiary of the Company. Beginning in the second quarter of 2014, the Company’s condensed consolidated financial statements include the non-controlling interest in the net income of IMAX China resulting from this transaction and the net proceeds are classified as redeemable non-controlling interest in temporary equity. Under the shareholders’ agreement, except under limited circumstances, holders of Class C Shares may not transfer any Class C Shares prior to the Second Completion Date. After the Second Completion Date, holders of Class C Shares may not transfer any Class C Shares except (i) to certain permitted transferees, (ii) pursuant to any sale of Class C Shares on the public market in connection with or following an IPO, and (iii) subject to the right of first offer of the holder of common A shares of par value $0.01 each in the authorized capital of IMAX China (the “Class A Shares”). With respect to transfers Class A Shares prior to an IPO, the shareholders’ agreement also provides certain drag-along rights to the holder of Class A Shares and certain tag-along rights and put rights to holders of Class C Shares. The board of directors of IMAX China will initially consist of nine members. The shareholders’ agreement provides that each of FountainVest and CMC has the right to nominate one member of IMAX China’s board of directors if it owns, (a) at any time prior to the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at the First Completion Date and (b) at any time following the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at both the First Completion Date and Second Completion Date. The holder of Class A Shares has the right to nominate seven members, among which one nominee shall be an independent director reasonably satisfactory to the holders of Class C Shares. The shareholders’ agreement entered into in connection with the transaction contains restrictions on the transfer of IMAX China’s common shares, certain provisions related to the composition of IMAX China’s board of directors and certain provisions relating to the redemption and share issuance in lieu of initial public offering of IMAX China’s shares and put and call rights relating to change of control of the Company. The shareholders’ agreement entered into in connection with the transaction provides that IMAX China intends to conduct an IPO of its shares by the fifth anniversary of the First Completion Date. If a qualified IPO (as defined in the shareholders’ agreement) has not occurred by such date, each holder of Class C Shares may request that all of such holders’ Class C Shares be, at their election, either: (i) redeemed by IMAX China at par value together with the issuance of 2,846,000 of the Company’s common shares in the event that the Second Closing is completed, or 1,423,000 of the Company’s common shares in the event only the First Closing is completed, (ii) redeemed by IMAX China at par value together with the payment by the Company in cash of the consideration paid by the holders of the Class C Shares, or (iii) exchanged and/or redeemed by IMAX China in a combination of cash and the shares of the Company equal to the pro rata fair market value of IMAX China. In the event that the Company reasonably believes that a transaction involving a change of control of the Company will occur, the Company will serve a notice on each holder of Class C Shares. Upon receipt of such notice, each holder of Class C Shares will have the right to cause the Company to purchase all of its Class C Shares, and the holder of Class A Shares will also have the right to purchase from each holder of Class C Shares all of its Class C Shares, each for consideration based upon the pro rata equity value of IMAX China. The shareholders’ agreement will terminate on the earliest to occur of (i) an IPO, (ii) a redemption or share exchange in lieu of an IPO after the fifth anniversary on the First Completion Date, (iii) completion of a put or call transaction pursuant to a change of control of the Company, and (iv) any date agreed upon in writing by all of the parties to the shareholders’ agreement. The shareholders’ agreement will also terminate with respect to any shareholder at such time as such shareholder no longer beneficially and legally holds any shares.

'

'

'

'

'

'In the second quarter of 2014, the Company announced the creation of the IMAX Original Film Fund (the “Film Fund”) to co-finance a portfolio of 10 original large-format films. The Film Fund, which is intended to be capitalized with up to $50.0 million, will finance an ongoing supply of original films that the Company believes will be more exciting and compelling than traditional documentaries. The initial investment in the Film Fund was committed to by a third party in the amount of $25.0 million, with the possibility of contributing additional funds. The Company, which will contribute $9.0 million to the Film Fund over five years, anticipates the Film Fund will be self-perpetuating, with a portion of box office proceeds reinvested into the Film Fund to generate a continuous, steady flow of high-quality documentary content. The related production, financing and distribution agreement includes put and call rights relating to change of control of the rights, title and interest in the co-financed pictures.

'

'

Non-controlling interest contract terms

'

'

'

'Under the shareholders’ agreement, except under limited circumstances, holders of Class C Shares may not transfer any Class C Shares prior to the Second Completion Date. After the Second Completion Date, holders of Class C Shares may not transfer any Class C Shares except (i) to certain permitted transferees, (ii) pursuant to any sale of Class C Shares on the public market in connection with or following an IPO, and (iii) subject to the right of first offer of the holder of common A shares of par value $0.01 each in the authorized capital of IMAX China (the “Class A Shares”). With respect to transfers Class A Shares prior to an IPO, the shareholders’ agreement also provides certain drag-along rights to the holder of Class A Shares and certain tag-along rights and put rights to holders of Class C Shares. The board of directors of IMAX China will initially consist of nine members. The shareholders’ agreement provides that each of FountainVest and CMC has the right to nominate one member of IMAX China’s board of directors if it owns, (a) at any time prior to the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at the First Completion Date and (b) at any time following the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at both the First Completion Date and Second Completion Date. The holder of Class A Shares has the right to nominate seven members, among which one nominee shall be an independent director reasonably satisfactory to the holders of Class C Shares. The shareholders’ agreement entered into in connection with the transaction contains restrictions on the transfer of IMAX China’s common shares, certain provisions related to the composition of IMAX China’s board of directors and certain provisions relating to the redemption and share issuance in lieu of initial public offering of IMAX China’s shares and put and call rights relating to change of control of the Company. The shareholders’ agreement entered into in connection with the transaction provides that IMAX China intends to conduct an IPO of its shares by the fifth anniversary of the First Completion Date. If a qualified IPO (as defined in the shareholders’ agreement) has not occurred by such date, each holder of Class C Shares may request that all of such holders’ Class C Shares be, at their election, either: (i) redeemed by IMAX China at par value together with the issuance of 2,846,000 of the Company’s common shares in the event that the Second Closing is completed, or 1,423,000 of the Company’s common shares in the event only the First Closing is completed, (ii) redeemed by IMAX China at par value together with the payment by the Company in cash of the consideration paid by the holders of the Class C Shares, or (iii) exchanged and/or redeemed by IMAX China in a combination of cash and the shares of the Company equal to the pro rata fair market value of IMAX China. In the event that the Company reasonably believes that a transaction involving a change of control of the Company will occur, the Company will serve a notice on each holder of Class C Shares. Upon receipt of such notice, each holder of Class C Shares will have the right to cause the Company to purchase all of its Class C Shares, and the holder of Class A Shares will also have the right to purchase from each holder of Class C Shares all of its Class C Shares, each for consideration based upon the pro rata equity value of IMAX China. The shareholders’ agreement will terminate on the earliest to occur of (i) an IPO, (ii) a redemption or share exchange in lieu of an IPO after the fifth anniversary on the First Completion Date, (iii) completion of a put or call transaction pursuant to a change of control of the Company, and (iv) any date agreed upon in writing by all of the parties to the shareholders’ agreement. The shareholders’ agreement will also terminate with respect to any shareholder at such time as such shareholder no longer beneficially and legally holds any shares.

'

'

'

'

'

'

'

'

Minority Interest Ownership Percentage By Noncontrolling Owners

'

'

'

'

20.00%

'

'

'

'

'

'

'

Shares issued

'

'

'

'

'

337,500

337,500

'

'

'

'

'

Shares issued par value

'

'

'

'

'

'

$0.01

$0.01

'

'

'

'

Aggregate subscription price

$40,491,000

$0

'

$40,000,000

'

$40,000,000

$40,000,000

'

'

$491,000

'

'

Board Of Directors Nomination Terms

'

'

'

'The board of directors of IMAX China will initially consist of nine members. The shareholders’ agreement provides that each of FountainVest and CMC has the right to nominate one member of IMAX China’s board of directors if it owns, (a) at any time prior to the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at the First Completion Date and (b) at any time following the Second Completion Date, at least 90.0% of the Class C Shares issued to such Person at both the First Completion Date and Second Completion Date. The holder of Class A Shares has the right to nominate seven members, among which one nominee shall be an independent director reasonably satisfactory to the holders of Class C Shares.

'

'

'

'

'

'

'

'

Common shares issued no IPO first closing completed

'

'

'

'

'

'

'

'

1,423,000

'

'

'

Common shares issued no IPO second closing completed

'

'

'

'

'

'

'

'

2,846,000

'

'

'

Number Of Years After Acquisition Put And Call Arrangement Becomes Exercisable

'

'

'fifth

'

'

'

'

'

'

'

'

'

Number Of Expected Original Films

'

'

'

'

'

'

'

'

'

10

'

'

Film Fund Expected Capital Contribution

'

'

'

'

'

'

'

'

'

50,000,000

'

'

Film Fund commitment amount

'

'

'

'

'

'

'

'

'

'

$25,000,000

$9,000,000

Contribution Period

'

'

'

'

'

'

'

'

'

'

'

5

Discontinued_Operations_Detail1

Discontinued Operations (Details Textuals) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Discontinued Operations And Disposal Groups [Abstract]	'	'
Reduction of rent expense related to discontinued operations	$0.80	$0